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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation organization 
This dissertation contains four main chapters. Chapter 1 includes a general 
introduction to the research problem and a literature review to orient the reader to relevant 
topics in the field. Chapters 2 and 3 are manuscripts that will be submitted for publication. 
Chapter 2 was formatted for the Journal of Immunology, and Chapter 3 was formatted for 
submission to Biology of Reproduction. A general conclusions chapter (Chapter 4) was 
also included to summarize the research findings and make recommendations for future 
smdies. Finally, an appendix was included that describes my attempts to clone the mitogen 
regulated protein receptor cDNA using expression cloning techniques. 
Introduction 
During pregnancy in viviparous mammals extensive interactions between fetal and 
maternal tissues occur. As part of establishing these contacts, a new maternal tissue known 
as the decidua, develops between the embryo and the uterine endometrium. The decidua 
has been proposed to have several roles during pregnancy, such as nourishing the embryo, 
establishing the placenta and facilitating parturition [1, 3, 6]. Although the decidua is 
required for normal pregnancy in viviparous mammals, examining its fimctions has been 
troublesome due to the complex interactions occurring between it and fetal tissues. In 
rodents, the decidua contains primarily two cell types, decidual cells, which are 
differentiated uterine stromal fibroblasts and granulated metrial gland (GMG) cells, which 
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belong to the natural killer cell lineage [1,3], Both of these cells types have been 
implicated in feto-matemal signal transduction and are therefore considered to play 
important roles in pregnancy success. This dissertation describes research on specific 
aspects of both GMG cells and decidual cells during murine pregnancy. 
GMG cells differentiate during pregnancy into activated natural killer cells that 
contain large quantities of cytolytic proteins [13, 14, 16-18]. However, GMG cell 
functions during pregnancy and the factors governing their differentiation are relatively 
unknown. Chapter 2 of this dissertation describes research on the temporal expression and 
regulation of the cytolytic mediators, granzymes D, E, F, and G, in uterine GMG cells 
during pregnancy, and it delineates a potential function for GMG cells in parturition. 
Uterine decidual cells undergo apoptosis in a progressive manner during pregnancy 
to accomodate the developing conceptus and to promote placentation and parturition [1,4, 
5]. The mechanisms governing decidual apoptosis, however, are not well understood. 
Chapter 3 of this dissertation describes research on the spatial and temporal expression of 
Bax, a potent cell death regulator, in the uterus during pregnancy. The temporal 
expression of Bax in decidual cells during pregnancy suggests that it may play a role in 
decidual apoptosis. 
Literature review 
Implantation and deciduaUzation in rodents: a general overview 
Successful pregnancy in viviparous mammals depends on extensive interactions 
between maternal and embryonic tissues. Embryonic implantation is the first step in 
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establishing feto-matemal contacts, and ultimately, its main purpose is to bring embryonic 
blood vessels into contact with the maternal blood. In the mouse, implantation occurs on 
day four to five of gestation (mouse gestation is 19-21 days), and it always occurs 
antimesometrially (Fig. lA) [1]. Successful implantation depends on the satisfactory 
development of the embryo as well as the receptivity of the uterus. The uterus undergoes 
dramatic changes in response to estrogen and progesterone during the preimplantation 
period in order for implantation to occur. During implantation the embryonic trophoblast 
cells penetrate the uterine lumenal epithelium resulting in death of epithelial cells by 
apoptosis [2], and by day six, the trophoblast cells begin to invade the maternal decidua. 
The iir^)lanting embryo stimulates a process known as decidualization that forms a 
new tissue within the adult uterus, the decidua. Decidualization is characterized primarily 
by the differentiation of stromal fibroblasts into decidual cells and by the proliferation and 
differentiation of granulated metrial gland (GMG) cells [3]. Initially, decidualization 
occurs antimesometrially smrounding the implanting embryo, and later it spreads 
mesometrially (Fig. IB-IQ. In the mouse, decidualization is complete by day nine, 
although by this time, the antimesometrial decidua has begun degenerating by apoptosis to 
increase the size of the implantation chamber for the developing conceptus (Fig. IC). The 
mesometrial decidua also regresses by apoptosis, but this does not begin until about day ten 
and proceeds until parturition, day 19 to 21 (Fig. ID) [1, 4, 5]. Over the years, many 
biological functions have been proposed for the decidua including: 1) nourishment of the 
embryo, 2) synthesis of cytokines and growth factors for use in paracrine and autocrine 
signaling, 3) control of trophoblast invasion and monitoring trophoblast integrity 4) 
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Figure 1. Schematic representation of the mouse uterus at different stages 
of pregnancy. A. The uterus prior to implantation. B. The uterus 
between days 4-6. C. The uterus at day 9. D. Mid to late gestational 
uterus. Abbreviations: M, myometriimi; MA, mesometrial area; 
L, limien; S, stroma; AMA, antimesometrial area; AMD, antimesometrial 
decidua; MD, mesometrial decidua; E, embryo; M6, metrial gland; 
P, placenta. 
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maternal immunoregulatory mechanisms, and 5) formation of a cleavage zone between the 
placenta and the uterine wall to facilitate parturition [1, 6] 
Granulated metrial gland (GMG) cells 
As part of decidualization in rodents, GMG cells (also known as uterine NK cells) 
become a predominant cell population within the decidua, and an analogous cell type, the 
endometrial granulocyte, has been identified in humans [7-9]. In the mouse, they can be 
detected in early gestation in the antimesometrial decidua, but starting at about day seven, 
GMG cells become localized to the mesometrial decidua and metrial gland where they 
remain until late gestation (Fig. ID) [10]. In addition, GMG cells are rare in virgin and 
postpartum uteri [11]. GMG cells have been proposed to have immunologic functions 
during pregnancy, because they belong to the natural killer (NK) cell lineage expressing the 
cell surface antigens, Thy-1, NKl.l, LGL-1, 3C2, asialo GM-1 and 4H12 [12-15] and they 
express cytolytic mediators, which is indicative of NK cell activation [14, 16-18]. Recent 
smdies, however, have also implicated them in non-immimologic roles such as 
placentation and embryonic development [19, 20]. 
Traditionally, GMG cells have been identified by their intense granular staining 
with the glycogen/glycoprotein specific stain, periodic acid Schiff s (PAS) reagent [10]. 
Subsequentiy, they were shown to express large amounts of the heterogeneously 
glycosylated and cytolytic proteins, perforin and granzymes A-B, within cytoplasmic 
granules [14, 16-18]. It is now well established that the intense PAS staining observed in 
GMG cells is a result of the accumulation of perforin and granzymes, as well as 
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extracellular matrix proteins [21] and degradative enzymes [22] over the course of 
gestation. 
The life cycle of GMG cells within the pregnant uterus is interesting, because once 
they begin to differentiate from their non-granulated to their granulated form, GMG cells 
become committed to a pathway that ultimately ends in death [23, 24]. GMG cells are 
mitotic until about day 10, and their differentiation, which occurs between days 6 and 15, 
is characterized by increases in both size and number of c)^oplasmic granules. However, 
GMG cells begin to undergo programmed ceU death at about day 12 and are virtually 
absent from the uterus by parturition [23, 24]. 
The granule exocytosis model 
As mentioned previously, GMG cells synthesize and store perforin and granzymes 
A-B within cytoplasmic granules. These proteins are cytolytic mediators utilized by 
activated T and NK cells to lyse tumor and virus infected cells. Thus, they are involved in 
cell-mediated immune responses. Although cytotoxic lymphocytes kill target cells by 
several mechanisms, the secretory pathway, also known as granule exocytosis, is believed 
to be the primary mechanism used in cell killing [25, 26]. According to this model, 
activated lymphocytes interact with target cells through receptor mediated mechanisms, 
perforin and granzymes are released from their granules into the area between the target 
and effector cell, and target cell death follows. Perforin, by a calcium dependent 
mechanism, has been postulated to form pores in the target cell membrane, and these pores 
are thought to allow granzymes to enter the cell and trigger death by apoptosis. 
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Granzymes are a family of serine proteases belonging to the chymotrypsin 
superfamily that are expressed exclusively in activated T and NK cell granules. Several 
granzyme genes have been cloned and characterized in mouse, rat and human cells. These 
include granzymes A through H, Tryptase-2, and Metase-1. In the mouse, granzymes A to 
G and Metase-1 have been isolated, whereas the human equivalents of mouse granzymes C 
to G have not yet been identified [27]. 
The granzymes are heterogeneously glycosylated on asparagine residues and are 
synthesized as preproproteins, such that the pro segment is an inactivating peptide. In 
addition, the leader peptides are thought to allow granzymes to be packaged into granules 
[27]. Members of the granzyme family are predicted to act on a variety of intracellular 
targets, because they have different amino acid specificities. For instance, granzyme A and 
Tryptase-2 are trypsin-like proteases that cleave after arginine and lysine residues, 
granzyme B cleaves after aspartic acid and glutamic acid residues, and Metase-1 cleaves 
after methionine and leucine residues. The amino acid specificities for granzymes C to H, 
however, are still unknown [27], 
The granzymes are thought to have distinct fimctions in mediating cell death. 
However, only granzyme B has been smdied extensively. This granzyme has been shown 
to induce DNA fragmentation, however it requires the presence of perforin to do so. 
Furthermore, perforin can lyse cells in the absence of granzyme B, but it cannot induce 
apoptosis [28, 29]. Recent studies using perforin and granzyme B knockout mice have 
demonstrated the critical roles played by these proteins in target cell killing. Analysis of T 
and NK cell cytotoxicity in perforin -/- mice revealed dramatic defects in target cell lysis. 
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For instance, CD8"^ T cells of perforin -/- mice could not lyse virus infected or allogenic 
target ceUs, and activated NK cells were incapable of lysing YAC-1 targets [30]. 
Granzyme B knockout mice have provided further evidence of a DNA fragmentation 
activity for granzyme B. Mice carrying a null mutation in the granzyme B gene had minor 
deficiencies in mediating cell lysis, as measured by cytoplasmic ^^Cr release, whereas their 
ability to induce target cell DNA fragmentation, as measured by '^ I-labeled DNA release 
was virtually absent. Furthermore, target cells had reduced morphological changes 
associated with apoptosis when incubated with activated granzyme B-/- CTL (cytotoxic 
lymphocytes)[31]. Cytoplasmic ^^Cr release is generally used to demonstrate target cell 
lysis, and this is thought to occur via the activities of perforin. Since target cell lysis was 
deficient in the granzyme B -/- mice, this suggested that granzyme B may be necessary in 
processing or polymerization of perforin [31]. Although this question remains unanswered, 
die profound decreases in DNA fragmentation and apoptosis observed in target cells 
incubated with granzyme B -/- effector ceUs strongly implicates granzyme B in DNA 
fragmentation events. Another interesting observation about granzyme B and perforin is 
that together they can induce all of the features associated with CTL mediated apoptosis 
[28, 29]. This observation has raised many questions regarding the potential fimctions of 
the remaining granzymes which remain to be elucidated 
Recently, members of the ICE (interleukin-ip converting enzyme)/CED-3 Family 
of cysteine proteases (also known as the Caspase Family) have been identified as potential 
substrates for granzyme B in vivo . The ICE family of cell death proteases was originally 
discovered in apoptotic cell deaths associated with the normal development of the 
9 
nematode, Caenorhabditis elegans, and subsequently many homologues were identified in 
humans [32-34], ICE proteases are activated by cleavage of inactive precursors at aspartic 
acid residues to form active heterodimers that induce apoptosis [35-37], Since granzyme B 
cleaves at aspartic acid residues, it became a candidate in ICE Family protease activation 
[38, 39], Granzyme B was shown to cleave and activate CPP32 (caspase-3) [38, 39] and 
several other ICE proteases [40, 41] but not ICE itself (caspase-1) [42], Furthermore, 
recent studies using specific ICE Family protease inhibitors have demonstrated that ICE 
proteases may be required in granzyme B/perforin mediated apoptosis [38], The ability of 
granzyme B to activate several ICE proteases suggests that activated lymphocytes may kill 
target cells by utilizing similar signaling pathways involved in the apoptotic programs 
associated with normal development. 
In contrast to granzyme B, granzyme A does not appear to play a primary role in 
cell mediated cj^otcxicity. Although a DNA fragmentation activity has been reported for 
granzyme A, mice carrying a null mutation in the granzyme A gene display normal cell 
mediated cytotoxicity [43], Therefore, a ftmction for granzyme A remains to be 
elucidated. 
Reproductive immunology: an historical perspective 
In 1953, Peter Medawar put forth an important question that has fascinated and 
driven reproductive ummmologists for years. He asked, "How does the pregnant mother 
continue to nourish within itself for many weeks or months a fetus that is an antigenically 
foreign body?" [44]. Traditionally, reproductive immimologists have maintained that the 
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fetus survives within the mother, because the maternal immune system is suppressed and 
the fetal immune system is immature [45]. Today, it is more widely accepted that the 
maternal immune system is not suppressed during pregnancy at all, and that immune 
fimction is actually controlled by complex c5^okine and hormonal networks established 
between embryonic and maternal cells at the feto-matemal interface. Moreover, the 
microenvironment which develops at the feto-matemal interface is governed by unique 
immunoregulatory mechanisms that cannot be equated with immunologic mechanisms that 
occur in other parts of the body [45]. Ultimately, the feto-matemal communication which 
occurs throughout gestation establishes a microenvironment that is immunologically 
acceptable for both the fetus and the mother, and at the same time provides an environment 
that stimulates proper embryonic development. 
Potential GMG cell functions during pregnancy 
Because GMG cells represent the predominant immune effector cell population in 
the pregnant uterus and they are located at the feto-matemal interface, their potential roles 
in the immimologic maintenance of pregnancy have intrigued investigators for years. 
However, as mentioned previously, recent studies have suggested their involvement in 
placentation and normal embryonic development as well. 
Over the years, GMG cells have been proposed to fimction in the following 
processes: [6, 46, 47] 
1). Regulation of trophoblast invasion into the maternal decidua. 
2). Monitoring trophoblast integrity. 
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3). Removal of virus infected uterine and placental cells. 
4). Cytokine production. 
5). Initiation of abortion and resorption of failed conceptuses. 
6). Destruction of extracellular matrix and decidua to facilitate parturition. 
Studies directed at testing some of these hypotheses are discussed below. 
Trophoblast invasion into the maternal decidua is a highly regulated phenomenon 
required for normal placentation and embryonic development. In women, excessive 
trophoblast invasion can result iu the decline of maternal health, and inadequate invasion 
may result in pre-eclampsia and still birth [48]. Although placentation is quite different in 
rodents and humans, the mouse is a good model system for studying these events. 
Understanding how trophoblast invasion is regulated is important to understanding the 
etiology of certain reproductive disorders and will also provide a better understanding of 
placentation in general. 
In rodents, GMG cells are often found in close proximity to degenerating 
trophoblast cells [49, 50], and the same is true in human pregnancy with the endometrial 
granulocytes. Thus, many investigators have proposed that rodent and human uterine NK 
cells may lyse trophoblast cells invading too deeply into the maternal decidua, or that they 
may remove abnormal trophoblast cells. In vitro smdies have demonstrated that both 
human and rodent uterine NK cells are cytotoxic to trophoblast cells [49, 50-52]. 
However, in some cases GMG cytotoxicity could only be demonstrated after activation 
with TL-2 [52]. Other studies have also indicated the cytotoxic activities of mouse GMG 
cells with the use of specific NK target cells such as fibrosarcoma Wehi 164 and YAC 
cells [53-55]. Furthermore, in the studies with Wehi 164 cells, Webster and Stewart 
presented evidence of granule exocytosis during GMG cell attack [56]. 
In the mouse, the period of GMG cell lytic activity concurs with the period of 
trophoblast invasion, days 6.5-9.5 of gestation [55]. However, the GMG ceU lytic activity 
does not correlate well with their expression of granzymes and perforin. Although GMG 
cells express perforin and granzymes A-B between days 6.5 and 9.5, they do not 
accumulate their highest levels of cytolytic mediators until mid-gestation or later [17, 57], 
Therefore, the reason for the accumulation of cytolytic mediators when GMG cells are no 
longer lytic is enigmatic and has suggested that there may be other roles for these cells 
during pregnancy. 
Delgado and coworkers recently suggested a role for GMG cells in parturition [24]. 
In these smdies, GMG cells were observed from mid-gestation until parturition to 
determine their mode of exit from the uterus in late pregnancy. GMG cells exhibited 
degenerative changes at day 12 including DNA fragmentation, cell enlargement, 
accmnulation of lipids and vesicles, plasma membrane degeneration, and cell rupture. 
Quantitative analysis of these events revealed that on day 12, approximately 50% of GMG 
cells were dead and by day 15 that number increased to 90%. Upon GMG cell rupture in 
late gestation, release of granule contents was observed. With these results, the 
investigators suggested that the serine proteases and degradative enzymes released from 
dying GMG cells may be required to solubilize the extracellular matrix and lyse decidual 
cells in preparation for placental separation and parturition. 
The analysis of GMG cells in pregnant transgenic mice has recently proven to be a 
powerful tool for gaining information about GMG cell functions. For instance, analysis of 
pregnant transgenic mice carrying the human CD3E gene (transgeneic strain, TgE26) that 
lack both T and NK cells revealed almost complete absence of GMG cells and the metrial 
gland [19]. In addition, placental size at day 14 was reduced by 45%, high rates of fetal 
loss were observed beginning on day ten, and 40% of the TgE26 offspring bom did not 
survive. Histological analysis of implantation sites during pregnancy revealed no 
significant abnormalities before day 10. However, between days 10 and 17 histological 
changes in the maternal arterioles were observed, including thickening of arteriole walls 
and accumulation of lipid-like material in the foam cells. By day 14, implantation sites 
containing viable fetuses demonstrated blood leakage into the decidua as well as neutrophil 
influx. At the same gestational stage, in implantation sites containing resorbing femses, 
vascular thrombosis was observed. These studies suggest that GMG cell fimctions are not 
important in early pregnancy events such as implantation, but they are in^)ortant in 
placental development, and most likely in the establishment of placental circulation. 
In addition to cytolytic mediators, GMG cells synthesize several cytokines during 
gestation including CSF-1, LIP, and EL-l [58]. CSF-I has been implicated in trophoblast 
differentiation and LBF receptors are expressed on trophoblast cells, decidual cells, certain 
embryonic cells and macrophages in the uterus. Since the placenta, decidua, and embryo 
appear to be affected in the NK cell deficient mice, it is possible that the lack of GMG cell 
cytokines plays a role in the abnormalities observed during pregnancy. In addition, the 
lack of perforin and granzymes at the feto-matemal interface may have been involved in the 
inadequate placental development. Since trophoblast cells did not over-invade the decidua 
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in these mice, this was interpreted to mean that GMG cells do not limit trophoblast 
invasion in vivo. However, GMG cells may normally attract trophoblast cells iato the 
decidua and then prevent their extensive invasion by cytolysis. If this is the case, the 
absence of GMG cells might result in incomplete placental development as well as defects 
in placental circulation due to the lack of trophoblast invasion into the decidua. 
Perforin knockout mice have also been examined during pregnancy [59]. As 
mentioned previously, perforin deficient mice display dramatic defects in target cell lysis. 
Normally, GMG cells interact with trophoblast cells, however GMG cells from perforin 
deficient mice rarely interacted with trophoblast cells. In addition, there were 
significantly higher numbers of GMG cells during pregnancy in the perforin -/- mice. 
Although the investigators observed these abnormalities, the perforin deficient mice had 
successful pregnancies with htter sizes similar to that of control mice. Furthermore, the 
perforin knockouts were capable of preventing virus transmission firom the mother to the 
ferns. Therefore, the authors concluded that perforin expression is either not essential for 
pregnancy or it is compensated for by a redundant mechanism. 
GMG cells have also been proposed to fimction in pregnancy failure. The mating 
of CBA/J females to DBA/2 males results in spontaneous abortion of 25-30% of fetuses by 
mid-gestation. Therefore, investigators have traditionally used this mating combination as 
a model for studying pregnancy loss. GMG cell depletion with anti-asialo GMl antibodies 
resulted in decreased numbers of resorptions using the CBA/J-DBA/2 mating combination, 
suggesting a role for NK activity in spontaneous abortion [60]. Further evidence for NK 
involvement in spontaneous abortion was shown by Gendron and coworkers. Using the 
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CBA/J-DBA/2 mating combination, they observed increased munbers of asialo-GMl 
expressing cells at resorption sites [61]. In contrast, other iavestigators have observed 
activated macrophages at presorption sites [62]. Therefore, the cells involved in this 
spontaneous abortion model remain unclear, but GMG and macrophage cells may play a 
role. 
GMG cell differentiation 
In general, T and NK cell differentiation and activation is manifested by the 
accumulation of cytol)^c mediators within cj^oplasmic granules. Several cytokines have 
been implicated in perforin and granzyme gene regulation in both T and NK cells, 
including IL-2, IL-6, IL-7, IL-12, and IL-15 [63-69]. Recently, IL-15 has been shown to 
upregulate perforin and granzymes A-B expression in GMG cell explants [57]. 
Of the above mentioned cytokines, IL-2 and IL-15 are the most likely in vivo 
candidates in GMG cell differentiation, because the remaining factors were undetectable in 
the placenta or the uterus during pregnancy [57, 58]. Expression of IL-2 mRNA has been 
reported in the human and murine placenta [70-72] and in human decidual NK and T cells 
[73, 74]. Albeit, IL-2 expression is reportedly quite low in these tissues. In contrast, high 
levels of IL-15 mRNA, have been reported in the murine placenta and uterus diu±Qg 
pregnancy [57, 75], 
IL-2 and IL-15 bind heteromeric receptors that stimulate JAK/STAT signal 
transduction pathways [76, 77]. In addition, these two cytokines share receptor subunits. 
IL-2 and IL-15 both utilize the IL-2 receptor P (IL-2Rp) and the IL-2 receptor y (IL-2RY) 
which are members of the cytokine receptor superfamily, but they each have unique alpha 
chains, the IL-2Ra and IL-15Ra [77-79]. Because IL-2 and IL-15 share receptor subunits, 
they were proposed to function similarly. Recent evidence suggests that these two 
cytokines do share similar activities such as stimulating proliferation and activation of T 
and NK cells [80, 81]. However, IL-15 is expressed in a wide variety of cells [75], 
whereas IL-2 is expressed exclusively in T-cells. Therefore, IL-15 is thought to have 
fimctions outside the immime system. Interestingly, IL-15 was recently shown to act as an 
anabolic agent in muscle cells [82]. The IL-2 and IL-15 receptor subimit mRNAs have 
been detected during pregnancy in the murine uterus [13, 57, 83, 84] and the IL-2 Ra, p, 
and Y proteins have been detected in the mouse uterus at various stages of pregnancy [83]. 
However, a complete analysis of GMG cells over the course of gestation for IL-2 and IL-
15 receptor expression is lacking, and it may aid in determining the in vivo regulators of 
GMG cell differentiation. 
Recently, GMG cells were shown to differentiate normally in IL-2 -/- mice during 
pregnancy [83]. The authors suggested that because GMG cells appeared normal in these 
knockout mice, IL-2 does not regulate GMG cell differentiation in vivo. However, they 
neglected to consider the possibility that IL-15 or perhaps other cj^okines involved in NK 
cell differentiation may compensate for the lack of IL-2. Since IL-2 and IL-15 are 
expressed at the feto-matemal interface during pregnancy, an analysis of GMG cell 
differentiation in a double knockout of IL-2 and IL-15 would be interesting and possibly 
more informative in regard to the in vivo regulation of GMG cell differentiation. 
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Decidual regression 
As mentioned in the first section of this literature review, the decidua contains 
primarily two cell types, GMG cells and decidual cells. In the following few sections, the 
topic of decidual regression will be addressed with special emphasis on potential regulatory 
factors involved. Finally, we will come full circle back to GMG cells and their possible 
involvement in decidual regression. 
Uterine decidual cells undergo apoptosis in a progressive manner during pregnancy. 
Initially, decidual cells die as a result of implantation as trophoblast cells invade their 
territory [5]. As the embryo grows within the implantation chamber, the antimesometrial 
decidua, which develops first, also degenerates first. This occurs between days six and ten 
in the mouse [4-5]. Finally, from about day 11 until parturition, the mesometrial decidua 
undergoes apoptosis [4] to provide space for the embryo, which at this time has begun to 
occupy the mesometrial chamber. Not only is decidual cell death required to accommodate 
the growing embryo, it is also required for normal placental development. Furthermore, 
mesometrial decidual apoptosis may be required in parturition, because the decidua is 
thought to act as a cleavage zone between the placenta and the uterine wall [1, 6] 
The bcl-2 gene family 
A few recent smdies have indicated that decidual cell apoptosis may be under the 
control of Bcl-2 family members. The bcl-2 gene was originally identified in chromosomal 
translocations that cause follicular lymphomas [85-87]. Subsequently, Bcl-2 was shown to 
act as a potent inhibitor of programmed cell death in many different cell types. For 
instance, Bcl-2 prevents hematopoietic cell death following growth factor withdrawal, it 
protects against neuronal cell deaths, and it may be important in normal embryonic 
development [88-90]. The recent cloning of several bcl-2 homologues has provided a 
better understanding of how apoptosis may be regulated by this gene family [91], Box and 
bcl-Xs, for instance are bcl-2 homologues that promote cell death [92, 93], whereas bcl-x  ^
is a homologue that ftmctions analogously to bcl-2 in promoting cell survival [93]. Smdies 
on the interactions between Bax and Bcl-2 have demonstrated that Bcl-2 homologues form 
homo and heterodimers through conserved BHl and BH2 (Bcl-2 Homology 1 and 2) motifs 
[92, 94]. Furthermore, Oltvai et al., demonstrated that Bax/Bax homodimers promote ceil 
death, while Bcl-2 may counter these effects by heterodimerization with Bax [92]. These 
smdies have indicated that the ratio of Bcl-2 family death effectors to death repressors 
within cells may determine their ultimate fate [92]. 
Potential roles for Bcl-2 and Bax in decidual regression 
In rodents, decidualization can be induced in the absence of an embryo by priming 
the uterus with estrogen and progesterone followed by stimulation of the uterine lumen 
with oil or other stimuli. This artificially induced decidua is referred to as the deciduoma, 
and it is thought to fimction similarly to the natural decidua that develops during pregnancy 
[3, 6]. Upon artificial induction of decidualization, Akcali et al., [95] observed an increase 
in bax mRNA and a concomitant decrease in bcl-2 mRNA suggesting that these genes may 
be under the control of progesterone and estrogen in the uterus. In addition, Bax protein 
expression increased in decidual cells as decidualization progressed, while Bcl-2 was noted 
to decrease. These results suggest that there is a shift toward the expression of cell death 
genes early in decidualization, and that the coordinated expression of Bcl-2 family members 
may regulate decidual apoptosis during pregnancy [95]. Bcl-2 protein expression has also 
been detected in the human decidua [96], and Piancentini and Autori noted decreased 
decidual Bcl-2 expression soon after implantation in the rat [97]. 
In addition to Bcl-2 and Bax, other Bcl-2 homologues have been detected in the 
uterus. Tilly and coworkers detected bcl-x mRNA expression in the immature rat uterus. 
However, these investigators did not examine tissues during pregnancy [98]. 
Potential GMG cell involvement in decidual regression 
GMG cells have been implicated in a variety of cell deaths associated with 
pregnancy. Their lytic activity may be important in regulating trophoblast invasion and 
integrity in early to mid-gestation [49-51]. As well, GMG cell degeneration in late 
gestation may release serine proteases and other degradative enzymes at the feto-matemal 
interface to promote extracellular matrix destruction and decidual cell death [24]. 
A plausible mechanism of decidual cell death is one in which GMG cells utilize 
cytolytic mediators to activate a death program in decidual cells that involves BcI-2 family 
members. Granzyme B has been shown to activate several ICE proteases [38-41], and ICE 
protease stimulated apoptosis can be inhibited by Bcl-2 [99, 100]. Perhaps the expression 
levels of Bcl-2 homologues within some cells provides another level of control in the 
apoptotic pathway. If this is the case, GMG cell activation of decidual cell apoptosis may 
depend on the expression levels of Bcl-2 death effectors and death suppressors within 
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individual decidual cells. In this model, only those decidual cells expressing high levels of 
Bcl-2 family death effectors would undergo apoptosis. 
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Abstract 
Granulated metrial gland (GMG) cells are NK cells that proliferate and differentiate 
within the murine uterus during pregnancy. They have been predicted to play important 
roles in nurturing the embryo, normal placentation, and uterine tissue remodeling. GMG 
cell differentiation is manifested by the accimiulation of the cytolytic mediators, perforin, 
granzyme A, and granzyme B, within cytoplasmic granules. The signaling mechanisms 
required for GMG cell differentiation are largely unknown, although recent in vitro assays 
have implicated IL-15 in these events. In this report, we demonstrate that granzymes D, E, 
F and G (granzymes D-G) are also expressed in GMG cells but at a later stage in 
pregnancy when compared with granzyme A expression. Whereas granzyme A is 
expressed in early to mid-gestation, the expression of granzymes D-G peak in mid to late 
gestation. In addition, we show that the IL-2RP and the IL-2RY mRNA, as well as the EL-
15Ra protein, are expressed concomitantly with granzymes D-G in the pregnant uterus. 
Finally, we demonstrate that granzymes D-G are upregulated by IL-2 and IL-15 in primary 
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cultures containing GMG cells. Taken together, these results suggest that IL-2 and/or IL-15 
may regulate GMG cell differentiation in vivo, and that granzymes D-G may have different 
fimctions than granzyme A during pregnancy. 
Keywords: reproductive inunxmology, cytokine receptors, cytokines, NK cells, rodent 
Introduction 
During pregnancy in viviparous mammals the uterus undergoes many changes to 
nurture and accommodate the developing conceptus. One change which occurs immediately 
following implantation is a process known as decidualization in which there is rapid uterine 
cell growth and differentiation. This "decidual reaction" is characterized primarily by the 
differentiation of stromal fibroblasts into decidual cells and by the proliferation and 
differentiation of granulated metrial gland cells (GMG) (I, 2). 
Murine GMG cells belong to the natural killer (NK) cell lineage (3-8), and an 
analogous cell type, the endometrial granulocyte, has been identified in humans (9-11). In 
the mouse, GMG cells are localized to the decidua and metrial gland in early to mid-
gestation and are confined to the metrial gland by late gestation. GMG cell differentiation 
begins at about day seven of gestation and is manifested by the accumulation of cytolytic 
mediators including perforin and the serine proteases, granzymes A and B, within 
cytoplasmic granules (7, 12-14). The murine granzymes, A and B, belong to a large family 
of serine proteases that includes granzymes C, D, E, F, G, H, Metase-1, and Tryptase-2 
(15). Cytotoxic T cells and NK cells utilize perforin and granzymes to facilitate tumor and 
virus infected cell death, however, the precise role of each granzyme has yet to be 
determined. Recent smdies of pregnant transgenic mice deficient in NK and T cells 
(transgenic strain, TgE26) revealed infrequent numbers of GMG cells, placentae half the 
size of control mice, and high rates of fetal loss after day 10. Histological analysis of 
implantation sites between days 10 and 17 revealed abnormalities in the establishment of 
placental circulation. These results suggest that GMG cell functions may not be important 
in early pregnancy events such as implantation, but they may be important in placental 
development (3,4). Although the functions of uterine GMG cells are unclear, they may 
regulate trophoblast invasion into the maternal decidua. Indeed, trophoblast killing by 
murine and human uterine NK cells has been reported (16, 17). Other possible GMG cell 
fimctions proposed in the past include: 1) lysis of virus infected cells present in the uterus 
and placenta, 2) initiation of abortion, 3) destruction of the extracellular matrix and cells at 
the placental/uterine interface to promote parturition, 4) nutritive functions, and 5) cytokine 
production (1, 18). 
Several cytokines have been implicated in perforin and granzyme gene regulation in 
both T and NK cells, including IL-2, IL-6, VL-1, IL-12, and IL-15 (19-25). Recentiy, IL-
15 has been shown to upregulate perforin and granzyme A-B expression in GMG cell 
explants (26). 
Understanding the mechanisms governing GMG cell differentiation during 
pregnancy will ultimately provide a better imderstanding of their fimction and relevance to 
pregnancy success. In this smdy, expression of the genes coding for granzymes D, E, F, 
and G (granzymes D-G) was found to be developmentally regulated in murine GMG cells 
during pregnancy. Granzymes D-G were shown to be expressed in late gestation, in 
contrast to the mid-gestational expression of granzyme A, suggesting different roles for 
granzymes D-G compared with granzyme A during pregnancy. Expression of the 
transcripts coding for the IL2RP and ELZRy, as well as n--15Ra protein, was detected in 
the uterus at the time when granzymes D-G are expressed. Finally, granzymes D-G were 
shown to be upregulated by both IL-2 and IL-15 in minced primary cultures containing 
GMG cells. Therefore, IL-2 and/or IL-15 may regulate GMG cell differentiation in vivo. 
Materials and Methods 
Animals and tissues 
Pregnant CF-1 mice were used. The morning a vaginal plug was observed was 
designated as day zero of pregnancy. For RNA isolation, uterine tissues removed from 
days 1-6 post-coitum also contained embryonic and placental tissue. Uterine tissues from 
days 7-19 of pregnancy were prepared with the embryos and placentae removed. 
Cytokines, antibodies, and cDNA clones 
Recombinant human IL-15 and recombinant mouse IL-2 were purchased from R & 
D Systems (Minneapolis, MN)- Rabbit polyclonal anti-mouse granzyme DEFG serum was 
a gift from Dr. Jiirg Tschopp (Universite de Lausanne, Lausanne Switzerland). Goat 
polyclonal anti-mouse IL-15Ra (N-19) was purchased from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA). Horse radish peroxidase-conjugated protein A was purchased from 
Sigma (St. Louis, MO). The mouse IL-2Ra and IL-2RY CDNAS were gifts from Dr. 
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Warren Leonard (NIH, Bethesda, MD). The mouse granzyme A cDNA was a gift from 
Irving Weissman (Stanford University, Stanford, CA). The rat glyceraldehyde-3-phosphate 
dehydrogenase (GPDH) cDNA was cloned by Fort et al. (27). 
Day 11 mouse uterine specific cDNA library construction 
Polyadenylated RNA was obtained from day II and day 18 mouse uterine total 
RNA using Invitrogen Fast Track mRNA isolation reagents (San Diego, CA). A 
subtractive library specific for day 11 uterine mRNA was constructed from day 11 and day 
18 uterine poly A"^ RNA using the PGR Select cDNA Subtraction Kit (Clontech, Palo Alto, 
CA) and the T- cloning vector, pTTBlue (R) (Novagen, Madison, WI). The day 11 uterine 
specific cDNA library contained approximately 10,000 primary recombinants. 
cDNA library screen using WSXWS oligonucleotides as probes 
The day 11 mouse uterine specific cDNA library was screened with degenerate 
oligonucleotides encoding the conserved WSXWS motif of the Type I cytokine receptors 
(WSXWS oligo-1; (A/G)CTCCAGGN(A/G)CTCCA and WSXWS oligo-2: 
(A/G)CTCCANTC(A/G)CTCCA (28). Briefly, the library was plated onto 150 mm LB 
agar plates containing 50 ^g/ml ampicillin and 15 ng/wl tetracycline at a density of 15,0(X) 
colonies per plate. Colonies were replica plated onto 137 mm, 0.45 micron nitrocellulose 
filters (Microcon Separations Inc., Westboro, MA), grown at 37°C overnight and 
incubated for an additional 8 h on LB agar plates containing 50 ^g/ml chloramphenicol. 
The bacterial colonies were then lysed and the DNA immobilized by baking at 90°C for 90 
min in a vacuum oven. The filters were washed briefly in 6 x SSC (1 x SSC: 150 mM 
NaCl and 15 mM sodium citrate, pH 7) and prehybridized at 37°C overnight in 6 x SSC, 2 
mg/ml BSA, 2 mg/ml Ficoil, 2 mg/ml polyvinyl pryrrolidone, 100 /xM ATP, 10 /ig/ml 
yeast tRNA, 2 mM sodiimi pyrophosphate, 2 mg/ml salmon sperm DNA, and 0.1 % NP40. 
The WSXWS oligonucleotides (250 pMol) were phosphorylated with T4 polynucleotide 
kinase (Promega, Madison, WI) and 250 /iCi y ^P-ATP (4500 Ci/mMol) to a specific 
activity of about 10® cpm/^g. Unincorporated ATP was removed using an STE Select-D 
G25 spin column (5 prime->3 prime, Boulder, CO). The oligonucleotides were hybridized 
at 37°C and 1 x 10^ cpm/ml for 28 h in the prehybridization buffer containing 0.1 % SDS 
instead of 0.1 % NP40. The filters were washed once for ten min at 24°C in 6 X SSC, 
twice for 30 min at 45°C in 6 x SSC and 0.1% SDS, and twice for 20 min at 45°C in 0.5 x 
SSC and 0.1 % SDS. The filters were exposed to film for 48-96 h at -70°C with 
intensifying screens and then developed. Colonies chosen from the primary screen were 
subjected to secondary and tertiary screens before pure clones were isolated and sequenced. 
Sequence analysis was performed with the University of Wisconsin Genetics Computer 
Group Sequence Analysis Software Package. 
cDNA library screen for genes expressed at mid-gestation but not late gestation in the 
uterus 
The day 11 mouse uterine specific cDNA library was plated as in the WSXWS 
screen. Prehybridization was carried out at 42°C overnight in 4.8 X SSC, 48% 
formamide, 2 mg/ml BSA, 2 mg/ml FicoU, 2 mg/ml polyvinyl pryrrolidone, 10% dextran 
sulfate, 0.1 % SDS, 10 /xg/ml yeast tRNA, and 20 mM Tris, pH 7.6. Day 11 and day 18 
mouse uterine cDNAs that had been previously synthesized for subtractive library 
construction were labeled with adCTP-^P using the Multiprime DNA Labeling System 
(Amersham, Arlington Heights, EL) to a specific activity of 2-4 x 10' cpm//ig. The 
unincorporated nucleotides were removed using an STE Select-D G25 spin column (5 
prime-*3 prime. Boulder, CO), the probes were each boiled for 10 min in 2 mg/ml salmon 
sperm DNA, placed on ice for 5 min and then hybridized to duplicate library filters for 16 
h at 42°C. The filters were washed three times for 15 min at 24°C in 2 x SSC/0.1 % SDS 
and twice for 20 min at 53°C in 0.2 X SSC/0.1 % SDS. Filters were exposed to fihn for 
60 h at -70 °C with intensifying screens and then developed. Clones that hybridized in 
duplicate to die day 11 but not the day 18 uterine cDNA probe were selected and 
rescreened until pure cDNA clones were isolated. cDNA clones were sequenced and 
analyzed as in the WSXWS screen. 
UNA isolation and Northern analysis 
Total RNA was isolated from frozen tissues using Trizol reagent (Gibco-Life 
Technologies, Grand Island, NY). For Northern analysis, 20-30 /xg of total RNA was 
separated by electrophoresis on a 1 % agarose gel containing formaldehyde and transferred 
to Zeta Probe-GT canonized nylon membranes (BioRad, Hercules, CA). ^^P-labeled 
cDNA probes were synthesized using the Multiprime DNA Labeling System (Amersham, 
Arlington Heights, IL) and hybridized at 47°C for 16-20 h in 7% SDS, 1 % polyethylene 
glycol (m.w. 15,000-20,000), 40% formamide, 0.1% NP40, 0.6 M NaCl, 5 mM EDTA, 
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100 Atg/ml yeast t-RNA, 100 pig/ml salmon sperm DNA and 40 mM sodium phosphate, pH 
7.4. Following hybridization, the membranes were washed twice at 24°C in 0.5 x SSC/ 
0.1% SDS and twice at 47°C in 0.2 x SSC/ 0.1 % SDS, each for 15 min. RNA transcripts 
were visualized by autoradiography and quantitated using ImageQuant software on a 
Phophorimager (Molecular Dynamics, Sunnyvale, CA). RNA bands for IL-2RP, IL-2RY. 
granzymes D-G, and granzyme A were normalized to that obtained for GPDH in each 
sample. 
Diagnostic RT-PCR analysis of granzymes D-G mRNAs 
For RT-PCR, total RNA from day 13 uterus or from the primary minced cell 
cultures was used. Primers of the following sequences were used: 
granzyme I primer, TTTAAC(T/A)CCTGTTAGAGCA, 
granzyme U primer, CTCT(C/T)(G/A)GAGCTGGAGCA. 
Reverse transcription was performed under the following conditions: 0.175 ng/fd 
total RNA, 0.5 pMol/^1 granzyme I primer, 1,000 units//il RNasin (Promega, Madison, 
WI), 0.5 mM dNTPs, 10 mM DTT, 10 units//xl Superscript n reverse transcriptase (Gibco-
Life Technologies, Grand Island, NY), 75 mM KCl, 3 mM MgClj, 50 mM Tris-HCl pH 
8.3. The reaction was allowed to proceed for 50 tnin at 42°C, and the reverse 
transcriptase was inactivated for 15 min at 70°C. The reaction mix was stored at -20°C 
until needed. 
PCR was performed on 15 % of the reverse transcription reaction under the 
following conditions: 0.8 pMol//xl each of granzyme I and granzyme n primers, 0.2 mM 
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dNTPs, 1.5 mM MgClj, 0.1% Triton X-100, 50 mM KCl, 10 mM Tris-HCl pH 9.0. The 
reaction mix was heated at 94°C for 3 min, and then 0.05 imits//il Taq polymerase 
(Promega, Madison, WI) was added to commence thermal cycling; thirty cycles were 
performed at 94°C for 45 sec, 56°C for 1 min, and 12°C for 1 min. One final cycle was 
performed at 72°C for 7 min. In some cases, a trace amount of adCTP-^P (0.1 /iCi/^1) 
was added to the PGR reaction mixes to label the products. 
Following the PGR, the samples were precipitated in ethanol and resuspended in 
water. Restriction analysis was performed with Bgin, BstXI, or HindlQ/Pstl (Promega, 
Madison, WI), and the DNA was resolved by electrophoresis on a 1.75% agarose gel 
containing 0.5 /rg/ml ethidiimi bromide. For ^P labeled PGR products, the gels were 
incubated in 10% TCA for 1 h, dried under vacuum, and exposed to Phosphorimager 
screens. The various DNA fragment intensities were determined using ImageQuant 
software on the Phosphorimager. 
To determine the relative levels of granzymes D-G mRNA, the specific DNA band 
intensities firom the Phosphorimager were divided by the corresponding restriction 
fragment size to obtain relative molar equivalents for all bands. The relative molar 
equivalents were then divided by the sum of all molar equivalents in the gel lane to estimate 
the fi^ction of the total represented by each granzyme present. 
Primary minced tissue culture 
Primary cell cultures were generated similarly to Ye et al. (26). Gultures were 
generated from day 8 of gestation and contained the entire implantation site. Briefly, the 
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implantation sites were dissected from the animal, minced into 4-6 pieces, rinsed in TBS, 
and cultured in aMEM (Gibco-Life Technologies, Grand Island, NY), 2% FCS, 20 mM 
HEPES pH 7.4, 10 U/ml penicillin/streptomycin. For some experiments IL-15 and/or IL-2 
were added to a final concentration of 300 ng/ml, and the culnires were maintained at 37°C 
for 24 h (19, 26). After the 24 h incubation, samples were frozen in liquid nitrogen and 
stored at -70°C prior to RNA isolation. 
Western analysis 
Protein was isolated from tissues by homogenization at 4°C in 0.15 M NaCl, 1 % 
NP40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/ml PMSF, 57 /ig/ml aprotinin 
(Sigma), 15 mM sodium phosphate, pH 7.4. After a 30 min incubation at 4°C, the tissue 
debris was removed by centrifiigation at 14,000 x^ for 20 min (4°C). Protein 
concentrations of the tissue lysates were determined using the Bradford assay. For 
Western blots, equal amounts of tissue lysate were resolved by SDS-PAGE on 7.5%-15% 
gradient gels and transferred to nitrocellulose (NitroBind, Micron Separations Inc., 
Westborough, MA). The anti-granzyme DEFG serum was used at a dilution of 1:250 and 
was detected with horse radish peroxidase-conjugated protein A (Sigma) and ECL western 
blotting detection reagents (Amersham). 
Immunohistochemistry 
Entire implantation sites from various days of gestation were fixed in 4% 
paraformaldehyde for 24 h at 4°C, embedded in paraffin and cut into 5 pun sections. The 
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sections were incubated with either the anti-IL-15Ra (N-19) Ab (1 /ig/ml) or the anti-
granzyme DEFG Ab (1:500), and the antibodies were visualized using an anti-
immunoglobulin-peroxidase stain (VectaStain ABC, Vector Laboratories, Burlingame, 
CA). Sections were then counter stained with periodic acid Schiff s (PAS) stain and/or 
hematoxylin. 
Periodic acid Schiff's (PAS) reaction 
Following immunohistochemistry, sections were treated with the following series of 
reagents: 0.5% periodic acid, 15 min at room temperature; 10 min under running water; 15 
min at 4°C in Schiff s reagent (26 mM sodium bisulfite, 15 mM basic fuschin, 0.15 N 
HCL); 20 sec under running water; 1 min in 2% sodium bisulfite; 5 min in water . The 
sections were then dehydrated to xylene, moimted with Permoimt and viewed on a Zeiss 
microscope. 
Statistical analysis 
The data obtained from the primary cultures treated with IL-15 and IL-2 was 
analyzed by linear combinations of the means (29). 
Results 
Gramymes D and G are expressed in the murine uterus at nud-gestation 
To identify genes expressed at mid-gestation but not late gestation in the uterus, a 
day 11 uterine specific cDNA library was constructed and was screened as follows. The 
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library was probed with radiolabeled cDNAs derived from day 11 and day 18 uterine 
mRNA, and clones hybridizing to the day 11 uterine probe but not the day 18 probe were 
selected. In the primary library screen, 26 clones were selected, and 12 of these were 
analyzed in a secondary screen. Following the secondary screen, four of the 12 clones 
were determined to be differentially expressed in the uterus. Three of these four clones 
encoded partial cDNAs approximately 600 bp in length that were 98% identical to the 
previously identified mouse granzyme G cDNA (EMBL/GenBank Accession Number 
J02872) (30). The remaining clone encoded a full length cDNA that was 99.7% identical 
to mouse granzyme D (EMBL/GenBank Accession Number J03255) (31). 
Temporal expression of granzymes D-G mRNA in the pregnant mouse uterus 
To determine if the genes coding for granzymes D and G were temporally regulated 
in the uterus during pregnancy, RNA isolated from uteri at various stages throughout 
gestation was analyzed by Northern blots. The granzyme D cDNA was used as a probe, 
because it would presumably detect both the homologous mRNA and that coding for 
granzyme G, owing to the 88% identity between these sequences. The mRNA transcripts 
were detected in the uterine samples between days 9 and 16 of pregnancy with peak 
expression between days 13 and 15 (Fig. 1). In contrast, the uterine expression of 
granzyme A was observed between days 8 and 13 and peaked on day 9 (Fig. 1). 
Jenne et al., reported the original cDNA cloning of granzymes D-G and 
demonstrated that die nucleotide identities among these granzymes range from 84-94% (30, 
31). Due to these high percentage identities, the granzyme D cDNA probe used in the 
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Figure 1. Temporal expression of granzymes D-G and granzyme A mRNA during pregnancy in the mouse uterus. 
Total uterine RNA was isolated and analyzed by Northern blot with labeled cDNA probes as described in the 
materials and methods. (Left): Quantitative results of granzymes D-G and granzyme A mRNA normalized 
to the GPDH mRNA in each sample. In most cases, days 1, 8, 16, and 19 represent a single sample. The remaining 
data from days 3, 5,7,9, 11, 13, 15, and 17 represent the average of 2-5 samples. To construct the final profiles, 
the average from each day of gestation was normalized to the average obtained at day 11 (day 11 was set at 100). 
(Right): Northern blots at day 11 of gestation showing hybridization of the^^-P labeled cDNA probes to granzymes 
D-G and granzyme A mRNA. 
Northern analysis (Fig. 1), even under high stringency conditions, presumably would 
hybridize to granzymes D, E, F, and G. To determine if all four of these transcripts are 
expressed during pregnancy, RT-PCR was performed and combined with a diagnostic 
restriction analysis. Briefly, primers were designed that would amplify granzymes D-G but 
not granzymes A, B, and C. Restriction analysis, with BstXI, Bglll, or a combination of 
Hindm/Pstl, was used to distinguish the mRNAs encoding granzymes D-G. Figure 2 
shows the results of the RT-PCR analysis on day 13 uterine RNA, and it demonstrates that 
granzymes D-G are expressed. Granzymes D-G were also detected in day 8 uterine RNA 
samples (not shown). Therefore, the Northern analysis shown in figure 1 actually 
represents the combined gestational profile of granzymes D, E, F, and G, not only 
granzymes D and G. 
Expression of granzymes D-G in uterine granulated metrial gland cells during pregnancy 
Cytolytic mediators such as perforin, granzyme A, and granzyme B have been 
localized to uterine GMG cell granules during pregnancy (7, 12-14). Examination of 
implantation sites by inmiimohistochemistry with an anti-granzyme D-G Ab, revealed that 
granzymes D-G are also expressed in GMG cells. Figure 3C shows intense granzyme 
immimoreactivity on day 15 of pregnancy in a large population of decidual cells but little 
staining in the placenta. The intense staining was also observed in the metrial gland located 
just above the decidua (metrial gland, not shown). Traditionally, GMG cells have been 
identified by their morphology and granular periodic acid Schiff s (PAS) staining (32, 33). 
The granzymes D-G stain was co-localized with the PAS stain in the sections analyzed 
Restriction Enzyme Gene Cut Fragment Size 
BstXI granzyme D 617, 115 
Hlndlll/Pstl granzyme E (Hlndlll/Pstl) 439, 161, 120 
granzyme F (Hindlll) 600, 120 
granzyme G (PstI) 659, 161 
Bglll granzyme F 434, 286 
granzyme G 622, 198 
124 BstXI 856 
granzyme D 
19 PstI Hindlll 739 
granzyme E u> 
ga Bglll Hindlll 818 
granzyme F 
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Figure 2. Granzymes D-G mRNA are expressed in the murine uterus during pregnancy. 
Day 13 uterine RNA was analyzed by RT-PCR, and granzymes D-G were identified by 
distinct restriction fragments created by Bglll, BstXI, or Hindlll/PstI digestion of the 
PGR products. (Left): A representative agarose gel showing the uncut and cut RT-PCR 
products. (Right): A digrammatic representation of granzymes D-G cDNAs showing the 
regions that were amplified by PGR and the DNA fragment sizes on the agarose gel. 
Figure 3. Distribution of granzymes D-G in uterine GMG cells during pregnancy. 
Implantation site sections from day 15 of gestation: (A) negative control, minus primary 
antibody (B) PAS stain (C) anti-granzyme DEFG antiserum (D) PAS stain and anti-
granzyme DEFG antiserum. The tip of the arrow in (B) denotes the interface between the 
decidua (above) and the placenta (below). GMG cells in the decidua were identified by 
their granular PAS staining (B) . The double stain with PAS and anti-granzyme DEFG 
antiserum confirmed that granzymes D-G are expressed in GMG cells (B, C, D). Final 
magnification of photographs, 65X. 

(Fig. 3B, C, and D), thus demonstrating that these proteins are expressed in the GMG 
cells. In addition, the granzymes D-G protein expression pattern in the uterus, as a 
function of gestation, was consistent with that obtained by Northern analysis. Granzymes 
D-G were detected between days 9-17 by Western blot and peaked between days 13 and 15 
(Fig. 4). A similar temporal expression of granzymes D-G observed by Western blot was 
observed by immunocytochemical staining of GMG cells at different stages of pregnancy 
(data from days 9.5, 11, and 17 not shown). 
Expression of IL-2RP, IL-2Ry, and IL-lSRain the uterus during gestation 
A second library screen was performed to isolate cDNAs encoding Type I cytokine 
receptors expressed in the mid-gestational uterus. In this screen, the day 11 uterine 
specific library was probed with ohgonucleotides encoding the conserved WSXWS motif 
found in this family of receptors (34). Two different oligonucleotides were used, 
WSXWS-1 and WSXWS-2 (see Materials and Methods). Using the WSXWS-2 
oligonucleotide, a partial IL-2RP ( — 130bp) cDNA was isolated. This clone was 99% 
identical to the previously identified mouse cDNA sequence (EMBL/GenBank Accession 
Number M28052). 
The expression of IL-2RP mRNA was examined in uterine tissues over the course 
of gestation and determined to be temporally regulated (Fig. 5). The IL-2RP mRNA was 
detected between days 8-15 and reached its highest level on day 9. In addition, the period 
of IL-2RP mRNA expression coincided with the expression of granzyme A and granzymes 
D-G mRNA (Fig. 1 and 5). 
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Figure 4. Mid to late gestational profile of granzymes D-G proteins in the mouse uterus. 
Uterine tissue lysates were prepared from several days of gestation and equal amounts of 
total protein were loaded in each lane and analyzed by Western blot. Granzymes D-G are 
heterogeneously glycosylated and migrate from 33-55 kd. 
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Figures. Temporal expression of the IL-2RP and IL-ZRy mRN A during pregnancy in the mouse uterus. Total 
uterine RNA was isolated and analyzed by Northern blot with^^.p labeled cDNA probes as described in the 
materials and methods. (Left): Quantitative results of IL-2Rp and IL-lRy normalized to the GPDH mRNA in each 
sample. Days 1,8, 16, and 19 represent a single sample. The remaining data from days 3,5,7, 9, 11, 13, 15, and 
17 represent the average of 2-3 samples. To construct the final profiles, the average from each day of gestation was 
normalized to the average obtained on day 11 (day 11 was set at 100). (Right): Northern blots at day 11 of gestation 
showing hybridization of the cDNA probes to IL-2RP mRNA (two bands within brackets) and 1L-2RY. The • 
represent 28S and 18S ribosomal RNAs. 
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The concomitant uterine IL-2RP and granzymes D-G expression prompted us to 
determine if EL-15 and/or IL-2 could regulate granzymes D-G expression in GMG cells. 
lL-2 signals via a high affinity receptor (IL-2Ra, IL-2RP, and IL-lRy) and an intermediate 
affinity receptor (IL-2RP and IL-2RY). Therefore, uterine tissues were analyzed by 
Northern blot to determine the expression patterns of the IL-2Ra and y subunits during 
pregnancy. The IL-2Ra mRNA was undetectable in the uterus during gestation (not 
shown). However, the IL-2RY subunit mRNA was present throughout gestation and 
increased between days 7-13 similarly to the IL-2RP subimit (Fig. 5). 
IL-15 utilizes a heteromeric receptor consisting of the IL-2RP, DL-2RY, and the EL-
15RA for signal transduction. To determine if the IL-15RA is present during the time of 
granzymes D-G expression, uterine tissue sections were examined by immimohistochemical 
methods with an anti-IL-15RA Ab. Specific IL-15RA staining was observed in the decidua 
at day 11 (Fig. 6A, 6B) but not on day 15 of gestation (Fig. 6C, 6D). 
IL-2 and ILrlS induction ofgranzyme D-G expression in primary cultures containing 
GMG cells 
The fact that the receptor subunits utilized in IL-2 and IL-15 signaling were present 
in the uterus at the time when granzymes D-G are expressed suggested that IL-2 and/or IL-
15 may regulate granzyme D-G expression in GMG cells. To examine this possibility, 
primary minced implantation sites (cultures included cells of the embryo, placenta, and 
uterus) firom day 8 of gestation were cultured with IL-2 and/or IL-15, and the amount of 
granzymes D-G mRNA present after 24 h was determined. A 2-5 fold increase in 
Figure 6. Distribution of IL-15Ra in the mouse uterus during pregnancy. Implantation 
site sections from day 11 (A, B) and day 15 (C, D) were stained with anti-IL-15Ra (B, D) 
or negative control, minus primary antibody (A, C). The tip of the arrow in (A) denotes 
the interface between the decidua (above) and the placenta (below). IL-15Ra was localized 
to the decidua on day 11 (B) but was undetectable on day 15 0)) and day 9 (not shown). 
Final magnification of photographs, 32X. 
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granzymes D-G mRNA was observed in the primary cultures incubated with IL-15, 
whereas cultures treated with IL-2 showed a 3-6 fold increase (Fig. 7). The combination 
of both cytokines resulted in a stimulation that was approximately equal to that obtained 
with either cytokine alone (not shown). To eliminate possible influences of other cells in 
the cultures, the effects of IL-2 and IL-15 were also tested in cultures containing the 
decidua alone. The effects of IL-2 and IL-15 on granzymes D-G mRNA were similar in 
cultures containing only decidual cells compared to those containing entire implantation 
sites (not shown). 
To determine if granzymes D-G are differentially regulated by IL-15 and IL-2, the 
RNA from the primary cultures was analyzed by RT-PCR and diagnostic restriction 
analysis as in Fig. 2. When the relative amoimts of the various granzymes were compared 
between stimulated and unstimulated samples, there was no significant difference in the 
relative amounts of any of the granzyme mRNAs (not shown). Thus, we conclude that IL-
2 and IL-15 equally increase the expression of granzyme D, E, F, and G mRNAs. 
Discussion 
In this report, the genes encoding granzymes D-G were shown to be temporally 
regulated in the mouse uterus during pregnancy. Furthermore, granzymes D-G were 
localized to uterine GMG cells between days 9.5-17 by immunohistochemistry. Perforin 
and granzymes A and B have also been localized to GMG cells (7, 12-14) with peak 
mRNA expression on day 9 of pregnancy (26). Our results show that the granzyme A 
transcript is expressed between days 7-13 with a sharp peak at day 9. In contrast, 
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Figure 7. The effect of IL-2 and IL-15 on granzymes D-G mRNA in primary implantation 
site cultures. Primary minced implantation sites from day 8 of gestation were cultured in 
the presence and absence of IL-2, IL-15 or both at 300 ng/ml for 24 hours. Total RNA 
was isolated from the cultures and analyzed by Northern blot with a ^-P labeled granzyme 
D cDNA probe. The mRNA band intensities for granzyme D-G mRNA were normalized 
to the GPDH mRNA in each sample using a Phosphorimager. Error bars show the sample 
standard errors of the mean (N =4, IL-15; N=3, IL-2). Figure 7 shows the results for one 
experiment with IL-15 and one experiment with IL-2. The effects of IL-2 and IL-15 were 
observed in 5 out of 6 experiments (IL-2, Ps 0.05 and IL-15, Ps 0.05). 
gramymes D-G mRNA expression occurs between days 8-16, with a broad peak between 
days 13-15. This finding supports the hypothesis that granzymes D-G may have different 
fimctions than granzymes A and B during pregnancy. In addition, this is the first report 
showing the expression of granzyme F in NK cells, as this granzyme was previously 
reported to have restricted expression in the CD4'CD8"^ subset of peripheral T cells (35). 
Many investigators have proposed that GMG ceUs may lyse placental trophoblasts 
invading the maternal decidua. Controlling the extent of trophoblast invasion is extremely 
important to the maintenance of pregnancy, because in humans diminished invasion may 
result in problems such as pre-eclampsia and still birth, while extensive invasion may cause 
maternal death due to uterine rupture (36). The granzyme A and B expression patterns are 
well timed with respect to the period of trophoblast invasion, and therefore, perhaps they 
play a role in these events. Furthermore, GMG cells only have lytic activity between days 
6.5 and 9.5 of gestation (37), and this lytic activity is coincident with granzyme A and B 
expression and with the period of trophoblast invasion. 
The late gestational expression of granzymes D-G suggests that these serine 
proteases may not be regulators of trophoblast invasion. Parturition, which requires 
considerable tissue remodeling, occurs between 19-21 days of gestation in the mouse. 
Although there is no experimental evidence supporting regulated granzyme secretion fi-om 
GMG cells, Croy proposed that granzymes may be released in late gestation to eliminate 
the extracellular matrix and cells at the uterine/placental interface to promote parturition 
(18). Experimental evidence in support of this h)rpothesis was recently demonstrated. 
Delgado et al., showed that GMG cells began to imdergo degenerative changes from day 12 
through parturition. Furthermore, degenerating GMG cells ruptured and released their 
granule contents in late gestation (38, 39). In this study, granzymes D-G proteins were 
detected between days 9-17 in the uterus. Mesometrial decidual regression begins at about 
day ten and continues until birth (2, 40). It is intriguing to suggest that granzymes D-G 
released from degenerating GMG cells in late gestation may prepare the feto-matemal 
interface for parturition. Although they are generally believed to be involved in cell-
mediated cytotoxicity, there is some evidence that granzymes can also participate in other 
events (41). 
The mechanisms governing GMG cell differentiation during pregnancy are not well 
understood and determining the signaling pathways required for their differentiation may 
ultimately lead to a better fimctional understanding of these cells. Northern analysis of 
uterine tissues revealed that the IL-2RP mRNA is temporally regulated during pregnancy. 
Although mouse uterine IL-2RP expression has been reported in the past (26, 42), its 
quantitative mRNA profile over the course of gestation has not previously been reported. 
In this study, IL-2RP subunit mRNA was shown to be expressed between days 8-16 with 
peak expression on day nine. This expression pattern, being concomitant with granzymes 
D-G, prompted us to investigate whether IL-2 and/or IL-15, the only cytokines known to 
bind the IL-2RP, regulate granzyme D-G expression and therefore GMG cell 
differentiation. Because IL-2 and IL-15 signaling occurs through several heteromeric 
receptors, uterine tissues from various days of gestation were anlayzed for the additional 
receptors that might be involved, the IL-2Ra, IL-2RY, and IL-15Ra. By Northern blotting 
the IL-2Ra mRNA was undetectable throughout gestation. In agreement with this restilt. 
Ye et al., also did not detect the IL-2Ra mRNA by RT-PCR (26). However, low levels of 
IL-2RA have been reported in the murine and human uterus by other investigators (42-44). 
The IL-2RY mRNA was present throughout gestation and increased at mid-gestation 
following a similar pattern to what was observed for the IL-2RP mRNA. Together, these 
experiments provide evidence that intermediate affinity IL-2 receptors (IL-2RP/IL-2RY) are 
present in the mouse uterus at mid-gestation. 
Immunohistochemical analysis of implantation site sections revealed mid-gestational 
expression of the IL-I5Ra. Using a polyclonal IL-15Ra antibody, the IL-15Ra was 
localized to the decidua on day 11, but it was undetectable on day 9 and day 15. Ye et al., 
also reported mid-gestational expression of mouse IL-15Ra in the uterus, but by RT-PCR 
analysis (26). Combined with our results of the IL-2RP and IL-2RY mRNA expression, 
these results suggest that an IL-15R composed of the IL-15Ra, IL-2RP, and IL-2RY may 
exist in the uterus at mid-gestation. 
To determine if E.-15 and/or IL-2 regulate granzyme D-G expression in GMG 
cells, primary minced tissue cultures that contained GMG cells were treated with both of 
these cytokines individually or together. GMG cells represent the predominant immune 
effector cell population in the rodent uterus during pregnancy (37). Therefore, any effect 
on granzymes D-G expression in these primary minced cultures may be attributed to GMG 
cells. IL-15 and IL-2 stimulated granzymes D-G expression to similar levels in day 8 cell 
cultures. The combination of IL-2 and IL-15 was not synergistic, suggesting that IL-2 and 
IL-15 may use the same signal transduction pathways in GMG cells. Of interest, however, 
are the results of Ye et al., which demonstrated IL-15 but not IL-2 regulation of granzymes 
SI 
A-B and perforin gene expression (26). This finding suggests that granzymes A-B and 
perforin may be regulated differently than granzymes D-G during pregnancy. 
In addition to Northern analysis, diagnostic RT-PCR was performed on RNA 
isolated from the primary cultures to determine if granzymes D-G were differentially 
regulated by IL-2 and IL-15. The analysis showed no change in the relative proportions of 
individual granzyme mRNAs after addition of IL-15 or IL-2. This suggests that the 2-6 
fold increase in granzymes D-G mRNA observed on Northern blots was due to the 
cumulative increase in the mRNAs encoding all four granzymes. 
Ultimately, the in vivo regulation of perforin, granzymes A and B, and granzymes 
D-G gene expression will depend on the presence of IL-2 and IL-15 in the local GMG cell 
environment. Expression of IL-2 mRNA has been reported in the human and murine 
placenta (45-47) and in human decidual NK and T cells (48, 49). Interestingly, Tangri and 
Raghupathy reported elevated IL-2 mRNA expression in the placentae of mice which are 
prone to high rates of spontaneous fetal resorptions (46). This is in agreement with other 
reports showing that elevated IL-2 levels have deleterious effects on pregnancy (50). Oxir 
results suggest that uterine GMG cells may be IL-2 targets in vivo. Since IL-2 is widely 
recognized in T and NK cell activation, and most activated T and NK cells express 
cytolytic mediators, elevated IL-2 expression may aberrantly activate GMG cells to a 
highly lytic state resulting in extensive cell lysis and abortion. 
IL-15 mRNA expression has also been reported in the placenta and uterus during 
pregnancy (26, 51). While IL-2 is expressed mainly in T cells, IL-15 has been detected in 
a wide variety of cells and tissues (51). This recently identified cytokine has been shown 
to function similarly to IL-2 in many instances (52, 53), while it is expressed in many 
different cell types and probably has fimctions outside the immime system. For example, 
IL-15 can act as an anabolic agent in muscle cells (54). Therefore, although our smdies 
and the results of others show that IL-15 may regulate GMG cell differentiation (26), it 
may have additional effects on GMG cells during pregnancy as well as distinct effects on 
specific granzymes. 
Although the in vivo regulators of GMG cell differentiation remain to be elucidated, 
the primary cultures in this study provide strong evidence that IL-2 and/or IL-15 may be 
iuvolved. In addition, the distinct expression patterns of granzyme A and granzymes D-G 
provide further evidence that granzymes may have several fimctions throughout pregnancy. 
Ultimately, determining granzyme functions during pregnancy may provide a better 
understanding of normal placentation, uterine tissue remodeling, and fetal/maternal 
interactions in general. 
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Abstract 
Decidual regression is a progressive apoptotic event that remodels the pregnant 
murine uterus to accommodate the fetus and promote placentation. Decidual regression is 
initiated in early gestation in the antimesometrial decidua and later spreads to the 
mesometrial decidua where it continues until only a thin decidual layer remains in late 
gestation. Recent investigations of the artificially induced deciduoma have suggested that 
the cell death regulators, Bax and Bcl-2, may be involved in decidtial regression dining 
pregnancy. Thus, the purpose of this study was to examine the spacial and temporal 
expression of Bax and Bcl-2 during pregnancy in the mouse uterus. Northern analysis 
demonstrated that the doxarmRNA is expressed at its highest levels between days 1-5 of 
pregnancy and declines steadily thereafter. Bcl-2 mRNA, however, was undetectable in the 
uterine tissues examined. Immimohistochemical analysis of pre-implantation uteri and mid-
gestational implantation sites with a Bax antibody was performed to determine the Bax 
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cellular localization in the uterus at different stages of pregnancy. Bax expression was 
observed in pre-decidual stromal cells on day 3 of gestation, three days prior to the 
initiation of antimesometrial decidual apoptosis. At day 9.5, regression in the 
antimesometrial decidua is complete, whereas mesometrial decidual regression is 
forthcoming. In day 9.5 sections, Bax expression was restricted to the mesometrial 
decidua. Together, these results suggest that Bax, a cell death effector, may regulate 
decidual apoptosis during pregnancy. 
Keywords: Bax, Bcl-2, uterus, decidua, pregnancy 
Introduction 
Apoptosis is a form of programmed cell death required for normal embryonic 
development and adult tissue homeostasis. In recent years, apoptosis has been shown to be 
important in the tissue remodeling that takes place within the rodent uterus throughout 
gestation to accommodate the developing conceptus. For instance, shortly after the 
blastocyst implants antimesometrially, uterine luminal epithelial cells undergo apoptosis, 
bringing trophoblast cells in closer proximity to the endometrial stroma [1]. This is 
necessary for normal implantation and yolk sac placentation [2]. Decidualization is 
characterized by proliferation and differentiation of uterine stromal cells. Upon 
implantation, decidualization begins antimesometrially, and later spreads mesometrially. 
As the conceptus grows within the implantation chamber, the antimesometrial decidua 
begins to regress by apoptosis [3,4]. By mid-gestation, death of epithelial cells lining the 
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mesometrial chamber has occurred which allows for placental development to proceed [2]. 
Finally, as the conceptus undergoes further development, it begins to occupy the 
mesometrial chamber. Thus, the mesometrial decidua also begins to regress by apoptosis 
and continues to do so until parturition [3, 4], 
The molecular mechanisms governing uterine apoptosis during pregnancy are 
largely unknown. However, members of the Bcl-2 gene family have recently been 
implicated in the these events. The bcl-2 protooncogene was originally discovered in 
chromosomal translocations in which the bcl-2 gene was juxtaposed with the Ig heavy chain 
locus [5, 6, 7], This translocation is very common in follicular lymphomas. Subsequently, 
Bcl-2 was shown to fimction as a potent inhibitor of programmed cell death in many 
different cell types [8, 9, 10, 11, 12]. Several Bcl-2 homologues have recently been cloned 
including bcl-x^, box, bcl-x^, bak, and bad [8, 13, 14]. Some of these proteins fimction in 
promoting cell death (Bax, Bad, Bak, Bcl-XG), while others fimction analogously to Bcl-2 in 
preventing cell death (Bcl-xJ. Recent smdies have demonstrated that the ratio of Bcl-2 
family death suppressors to death effectors within a cell may determine whether it lives or 
dies [13]. 
There is some evidence that Bcl-2 and Bax play a role in uterine decidual apoptosis 
that occurs during pregnancy. The Bcl-2 protein, for instance, has been localized to the rat 
and human decidua [15, 16]. Furthermore, Akcali et al. [17], demonstrated that treatment 
of ovariectomized rats with estradiol/progestin resulted in an increase in uterine bax a 
mRNA and a concomitant decrease in bcl-2 mRNA. Following hormone treatment, 
decidualization was artificially induced. In-sim hybridization and immunohistochemical 
analysis of uterine tissues revealed that as decidualization progressed, bcaa mRNA and 
protein were first evident in the periluminal decidua and then spread throughout the 
decidua. In contrast, bcl-2 mRNA and protein were virtually undetectable in the decidua. 
Taken together, these results suggest that the Bax and Bcl-2 levels within uterine decidual 
cells may change during decidualization, and that Bax may regulate decidual apoptosis. 
The purpose of the present swdy was to examine the spacial and temporal 
expression of Bax and Bcl-2 in the uterus during pregnancy. A combination of Northern 
analysis and immunohistochemistry was used to determine the expression of bax and bcl-2 
mRNA and Bax protein cellular localization in the uterus at different stages of pregnancy. 
Materials and Methods 
Animals and tissues 
Pregnant CF-1 mice were used. The morning a vaginal plug was observed was 
designated as day zero of pregnancy. For RNA isolation, uterine tissues removed from 
days 1-6 post-coitum also contained embryonic and placental tissue. From days 7-19 of 
pregnancy, uterine tissues were prepared with the embryos and placentae removed. 
Antibodies and cDNA clones 
Rabbit polyclonal anti-mouse Bax (P19) antibody and blocking peptide were 
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). The mouse bcl-2 and 
bax cDNA clones were generous gifts from Dr. Stanley Korsmeyer (Washington 
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University School of Medicine, St. Louis, MO). The rat glyceraldehyde-3-phosphate 
dehydrogenase (GPDH) cDNA was cloned by Fort et al. [18]. 
SNA isolation and Northern analysis 
Total RNA was isolated from frozen tissues using Trizol reagent (Gibco-Life 
Technologies, Grand Island, NY). For Northern analysis, 20-70 (ig of total RNA was 
separated by electrophoresis through a 1 % agarose gel containing formaldehyde and 
transferred to Zeta Probe-GT cationized nylon membranes (BioRad, Hercules, CA). 
^P-labeled cDNA probes were synthesized using the Multiprime DNA Labeling System 
(Amersham, Arlington Heights, IL). The box probe was synthesized from an 800 bp 
EcoRI/XhoI cDNA fragment, and the bcl-2 probe was generated from an 865 bp 
Hindm/EcoRI cDNA fragment. Probes were hybridized at 47°C for 16-20 h in 7% SDS, 
1% polyethylene glycol (m.w. 15,000-20,000), 40% formamide, 0.1% NP40, 0.6 M 
NaCl, 5 mM EDTA, 100 /ig/ml yeast tRNA, 100 /xg/ml salmon sperm DNA and 40 mM 
sodiimi phosphate, pH 7.4. Following hybridization, the membranes were washed twice at 
24°C in 0.5 x SSC/ 0.1% SDS, twice at 47°C in 0.2 x SSC/ 0.1% SDS, and twice at 55°C 
in 0.1-0.2 x SSC/ 0.1% SDS each for 15 min (1 x SSC: 150 mM NaCl, 15 mM sodium 
citrate, pH 7). RNA transcripts were visualized by autoradiography and quantitated using 
ImageQuant software on a Phophorimager (Molecular Dynamics, Sunnyvale, CA). The 
relative intensity of the box mRNA band was normalized to that obtained for GPDH 
mRNA in each sample. 
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Immunohistochendstry 
Entire implantation sites from days 9.5 and 11 of gestation and uteri of day three or 
non-pregnant mice were fixed in 4% paraformaldehyde for 24 h at 4°C, embedded in 
parafBn and cut into 5 /xm sections. The sections were incubated with the anti-Bax (P19) 
antibody (0.5-1.0 /ig/ml), and the antibodies were visualized using an anti-
immxmoglobulin-peroxidase stain (VectaStain ABC, Vector Laboratories, BurUngame, 
CA). Sections were then counter stained with hematoxylin, dehydrated to xylene, mounted 
with Permount, and viewed on a Zeiss microscope. 
Results 
Total uterine RNA from non-pregnant and pregnant mice was analyzed by Northern 
blot for the expression of box and bcl-2 mRNA. Bca mRNA is alternatively spliced into 
two forms, baxa (1 kb) and baxP (1.5 kb) [13]. Only the haxa message was detected in 
die uterine samples. During pregnancy, the baxo. transcript was highest between days 1-5 
and declined steadily thereafter (Fig. lA, IB). In addition, the amount of baxo. message 
observed in non-pregnant mouse uteri was similar to that observed between days 1-5 of 
pregnancy (Fig. lA). The bcl-2 mRNA, however, was undetectable in the uterine samples 
examined (data not shown). For the initial Northern blots, 20 ^g of total RNA was used. 
In subsequent attempts to detect the bcl-2 message, 50 and 70 /xg of RNA was used in the 
Northern blots, but the bcl-2 mRNA remained undetectable. Because there was no 
detectable bcl-2 mRNA expression in the uterus during gestation, it was not examined 
further. 
Figure 1. Teiiq)oral expression of baxa mRNA in the non-pregnant and pregnant uterus. 
Total uterine RNA was isolated and analyzed by Northern blots. (A) Quantitative results 
of baxa mRNA normalized to the GPDH mRNA in each sample. The data represent the 
average of 2-3 uterine samples from each day tested during pregnancy and 3 samples from 
non-pregnant uteri. (B) Representative Northern blots showing hybridization of the ^-P 
labeled cDNA probes to baxa and GPDH mRNA in total uterine RNA samples from day 1 
through 19 of gestation. 
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The Northern analysis suggested that Bax may play a role in uterine tissue 
remodeling during pregnancy. Therefore, to examine the cellular localization of Bax (p21) 
protein, a polyclonal anti-Bax (p21) antibody was utilized in immunohistochemical analysis 
of tissue sections from non-pregnant and pregnant mice. In the non-pregnant uterine 
sections, Bax staining was most apparent in the circular and longitudinal myometrium, and 
there was also light staining in the stromal cells (Fig. 2C). On day 3 of pregnancy, Bax 
expression in the circular and longitudinal myometrium, as well as the stroma, appeared to 
increase when compared to the non-pregnant samples (Fig. 2C, 2D). Additionally, Bax 
expression was noted in the glandular epithelial cells on day 3, whereas it was not detected 
in these cells in non-pregnant samples (Fig. 2C, 2D). Bax expression was also observed in 
the glandular epithelial cells of day 9 sections (Fig. 2F). To verify the antibody's 
specificity for Bax, a Bax antigenic peptide was added to some of the sections analyzed. 
Figure 2B and 2E show that the Bax antigenic peptide abolished Bax antibody binding to 
the stromal and glandular epithelial cells on day 3. However, addition of die peptide 
resulted in incomplete competition in the circular and longimdioal myometrium. 
By day 9.5, much of the antimesometrial decidua has undergone apoptosis to 
provide more space for the embryo withio the implantation chamber, while the mesometrial 
decidua remains healthy and does not begin to regress until about day 11. As can be seen 
in figure 3A and 3C, there was very little Bax immunoreactivity in the residual 
antimesometrial decidua on day 9.5. In contrast, the mesometrial decidua demonstrated 
intense Bax staioing. Bax expression was also noted in the trophoblastic giant cells in both 
antimesometrial and mesometrial regions, as well as in the circular and longimdinal 
Figure 2. Bax distribution in the uteri of non-pregnant and day 3 mice. (A) Day 3 uterus, 
anti-Bax antibody, final magnification, 16X. (B) Day 3 uterus, anti-Bax antibody plus Bax 
antigenic peptide, 16X. (C ) Non-pregnant uterus, anti-Bax antibody, final magnification, 
65X. (D) Day 3 uterus, anti-Bax antibody, 65X. (E) Day 3 uterus, anti-Bax antibody plus 
Bax antigenic peptide, 65X. (F) Day 9 uterus, anti-Bax antibody, 65X. The boxed area in 
Fig. 2B is magnified in Fig. 2D-E and a similar region in Fig 2C. The glandular epithelial 
cells in Fig. 2F were located in the antimesometrial region. Abbreviations: L, longitudinal 
myometrium; C, circular myometrium; S, stroma; Ln, lumen; G, glandular epithelixmi. 
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Figure 3. Bax distribution in the day 9.5 uterus. (A) anti-Bax antibody, final 
magnification, 16X (B) anti-Bax antibody plus Bax antigenic peptide, 16X. (C) anti-Bax 
antibody, final magnification, 32X. (D) anti-Bax antibody plus anti-Bax antigenic peptide, 
32X. The boxed area in Fig. 3B is magnified in Fig. 3C-D. Abbreviations: MD, 
mesometrial decidua; AMD, antimesometrial decidua; E, embryo; C, circular 
myometrium; L, longimdinal myometriimi; T, trophoblastic giant cells. 
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myometrium (Fig. 3A, 3C). Addition of the Bax antigenic peptide abolished nearly all of 
the staining observed in the day 9.5 sections (Fig. 3A-3D). 
Discussion 
Uterine cellular apoptosis has been well documented at various times and locations 
during gestation [1, 2, 3, 4, 15]. Because the embryo implants antimesometrially, apoptosis 
occiirs in this location initially to promote embryonic growth and development. At mid-
gestation, the mesometrial decidua begins to regress to foster placentation and ultimately 
parturition. 
Bcl-2 enhances the survival of many different cell types [9, 10, 11, 12, 13], 
whereas Bax promotes cell death [13]. Members of the Bcl-2 family form homo and 
heterodimers through conserved motifs, BHl and BH2 (Bcl-2 Homology 1 and 2) [19]. 
Smdies on the interactions between Bax and Bcl-2 have shown that the activities of these 
proteins depend on their interactions such that increased concentrations of Bax/Bax 
homodimers promote cell death, while Bcl-2 may counter these effects by 
heterodimerization with Bax. Thus, the ultimate fate of a cell may depend on the ratio of 
death effectors to death repressors present [13, 19]. 
Recent smdies have indicated that Bcl-2 homologues may fimction in uterine 
decidual apoptosis [15, 17, 20]. The focus of the present smdy was to determine if there 
was a correlation between spacial and temporal uterine Bax and Bcl-2 expression levels and 
decidual regression. 
Northern analysis showed that the teca transcript is expressed at approximately 
equal levels in the non-pregnant uterus and the uterus between days 1-5 of pregnancy. 
After day 5, the feoxar message declines steadily until the end of pregnancy. 
Immunohistochemical analysis demonstrated Bax expression in several uterine cell types 
(circular muscle, longimdinal muscle, glandular epithelixmi, and decidua) during 
pregnancy. Therefore, it is difficult to interpret the significance of the bax a mRNA profile 
with respect to a single cell type. However, the beginning of baxcc mRNA decline 
observed on day 5 coincides with the initiation of antimesometrial decidual apoptosis. 
Immimohistochemical analysis of uterine sections showed that on day 3 Bax was expressed 
in pre-decidual stromal cells. In addition, die day 9.5 sections revealed Bax expression in 
the mesometrial decidua. Thus, if Bax is involved in decidual apoptosis in the 
antimesometrium io early gestation and the mesometriirai in mid to late gestation, the 
gradual decline in ^?axarmRNA expression may reflect the temporal program of decidual 
cell death in the uterus. 
The lack of uterine bcl-2 mRNA expression was unexpected, but correlates with 
reports from other smdies. Piacentini and Autuori detected low Bcl-2 protein levels in the 
pregnant rat decidua just after implantation but could no longer detect it by day 9 [15], 
This corresponds to approximately day 7.75 in the mouse. It is noteworthy that regression 
in the antimesometrial decidua occurs at the time when Bcl-2 is declining in the decidua. 
Furthermore, Akcali et al. [17], observed negligible bcl~2 mRNA expression in the 
artificially induced decidua by in situ hybridization. In conjimction with our Northern 
analysis, these results provide evidence that the bcl~2 gene is either turned off early in 
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gestation or is expressed at very low levels. Therefore, because Bcl-2 levels are low, Bax 
may shift the cells toward a death pathway. Alternatively, other Bcl-2 family death 
repressors may coimter the Bax activity in the decidua. BC1-XL, one of these death 
repressors, is expressed in the immature rat uterus [20]. An analysis of bcl-x^^ mRNA 
expression in the pregnant uterus would aide in elucidating whether or not this protein is 
involved in suppressing decidual regression at specific times during pregnancy. 
The immimohistochemical analysis of uterine sections at different times during 
pregnancy suggests that Bax may be involved iu both antimesometrial and mesometrial 
decidual apoptosis. Bax expression was observed in pre-decidual stromal cells on day 3, 
three days before antimesometrial decidual regression begins. By day 9.5, Bax expression 
in the antimesometrial decidua was undetectable, while it was quite high in the mesometrial 
decidua. This is a striking observation, because on day 9.5 decidual cell regression in the 
antimesometrial area is complete and mesometrial decidual regression is forthcoming on 
about day 11. 
The significance of the myometrial Bax expression is unclear. However, Bax 
expression in the circular and longimdinal myometriim has been reported in the artificially 
induced decidua and in non-pregnant uteri [17]. These authors suggested that Bax 
expression in the layers of the myometrium may be necessary in remodeling the 
myometrium in response to increased decidual volume and intrauterine pressure associated 
with pregnancy. Bax expression in the non-pregnant uterus may be related to apoptotic 
events which take place during the estrus cycle. 
Glandular epithelial cells at day 3 and 9 expressed Bax protein, while in the non­
pregnant uterus it was undetectable in these cells. Bcl-2 protein has also been localized to 
glandular epithelium of tissues that undergo hyperplasia and involution in response to 
hormones, growth factors or other stimuli. These tissues included breast, thyroid, 
prostate, pancreas and the gastroiniestinal tract [21]. Furthermore, Bcl-2 has also been 
localized to the glandular epithelium of the artificially induced decidua [17]. Because the 
uterus also undergoes periods of hyperplasia and involution, the expression of Bcl-2 and 
Bax in uterine glandular epitheliimi may be related to these processes. 
The trophoblastic giant cells expressed significant levels of Bax protein on day 9.5 . 
At mid-gestation, the giant cell layer is six to seven cells deep and is reduced to zero to 
four cells by late gestation [22]. Because trophoblastic giant cells do not display 
degenerative changes until day 13, and Bax is present on day 9.5, this suggests that Bcl-2 
or some other factor may be expressed in the giant cells before day 13 to protect them from 
the effects of Bax. Although Bcl-2 expression has been reported in hxmaan trophoblasts 
[23], its expression has not been examined during gestation in the mouse. 
In conclusion, the spacial and temporal Bax expression observed during pregnancy 
in the murine uterus suggests that Bax may play a role in antimesometrial as well as 
mesometrial decidual apoptosis. With low Bcl-2 expression in the decidua, Bax expression 
m decidual cells may shift diem toward a cell death pathway. In addition, Bax may have 
otiier functions during pregnancy as it was detected in the myometrium, glandular 
epitheliimi, and trophoblastic giant cells. Studies on the expression of other Bcl-2 family 
members in the uterus may provide the necessary framework to decipher the signaling 
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pathways utilized in uterine tissue remodeling during pregnancy. Because apoptosis has 
been implicated in many human diseases, understanding the mechanisms of cell death that 
occur in the mouse uterus during pregnancy may be relevant in determining the etiology of 
human reproductive disorders such as pre-eclampsia and endometriosis. 
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CHAPTER 4: GENERAL CONCLUSIONS AND 
RECOMMENDATIONS 
In the first paper (Chapter 2), the day 11 uterine specific cDNA library was 
constructed and screened in an effort to identify novel genes expressed in the mid-
gestational uterus. Although all of the genes isolated using the WSXWS and the 
differential library screens had previously been cloned by other investigators, new 
information regarding their specific gene expression and regulation in the pregnant uterus 
was obtained in this research. Furthermore, this work has provided evidence for granzyme 
functions in late gestation. 
Granzymes D and G were isolated in the differential library screen, and further 
analysis using RT-PCR also confirmed the expression of Granzymes E and F in the uterus 
during pregnancy. Northern analysis and immunohistochemistry showed that Granzymes 
D-G are expressed in mid to late gestation (between days 11-17) in uterine GMG cells. 
Granzyme G is the most highly expressed, while granzymes D, E and F are expressed at 
lower but approximately equal levels. Granzymes A and B have also been identified in 
GMG cells during pregnancy [1,2], but their expression patterns are quite different firom 
that of granzymes D-G. Whereas granzymes A and B mRNA expression peaks at mid-
gestation, granzymes D-G do not peak imtil late gestation, between days 13-15. 
Combined with the current knowledge of granzyme expression and GMG cells 
during pregnancy, our results suggest several new possibilities. First, the different 
expression patterns observed for granzymes A-B compared to granzymes D-G indicate that 
granzymes may play roles in botli mid and late gestation. Second, granzymes D-G may 
have unique roles during pregnancy. Granzymes are typically utilized in target cell killing 
by T and NK cells, but granzymes D-G are not expressed in GMG cells during their lytic 
phase which occurs between days 6.5-9.5. This implies alternative roles for these 
granzymes during pregnancy. Recent studies revealed that granule contents are released 
from degenerating GMG cells in late gestation suggesting that granzymes and other 
degradative enzymes may be involved in the local degradation of ECM and decidua at the 
feto-matemal interface that facilitates parturition [3]. Granzymes D-G are candidates in 
this function due to their temporal and spacial expression during pregnancy. Antibody 
depletion smdies in late gestation using anti-granzyme D-G antibodies may help to elucidate 
whether these proteins are involved in parturition. 
The IL-2RP cDNA isolated in the WSXWS library screen was analyzed by 
Northern blot to determine its temporal mRNA expression in the uterus during pregnancy 
and found to be coincident with that of granzymes D-G. Because the IL-2RP is involved in 
IL-2 and IL-15 signaling, this suggested that one or both of these cj^okines may be 
involved in granzymes D-G gene regulation and therefore GMG cell differentiation. To 
test this hypothesis we examined uterine tissues for the other receptor subunits required LD 
IL-2 and IL-15 signaling and also tested the effects of IL-2 and IL-15 on granzymes D-G 
mRNA expression levels in primary cultures containing GMG cells. By Northern analysis 
the IL-2 Ra was undetectable during pregnancy in the uterus, but the IL-2RY mRNA had a 
similar profile to the IL-2RP subunit. These results demonstrated that intermediate affinity 
JL-2 receptors are present in the uterus at the time of granzymes D-G expression. Using 
immunohistochemical analysis the E.-15Ra was localized to the decidua at mid-gestation. 
Combined with the Northern results, this data supports the expression of high affinity IL-
15 receptors in the uterus (composed of IL-2RP, IL-2RY and IL-15Ra) at the time of 
granzymes D-G expression. When primary cultures containing GMG cells were incubated 
with IL-2 and/or IL-15, granzymes D-G mRNAs increased by 3 to 6 and 2 to 5 fold 
respectively. Because both IL-2 and IL-15 have been detected at the feto-matemal interface 
during pregnancy, die in vivo regulator(s) remain to be identified. IL-2 knockout mice 
demonstrated a normal GMG cell population during pregnancy suggesting IL-2 may not be 
required for GMG cell differentiation [4]. However, IL-15 may compensate for the lack of 
IL-2 expression in these mice. Therefore, an analysis of IL-15 and IL-2/IL-15 knockout 
mice during pregnancy may provide a better understanding of GMG cell differentiation and 
granzymes D-G gene expression in vivo. 
Apoptosis of uterine cells occurs at specific times and locations during pregnancy, 
but the molecular mechanisms governing these events remain largely imknown. To begin 
examining potential regulators of uterine apoptosis, the focus of the second paper (Chapter 
3) was to examine the temporal and spacial expression of the programmed cell death 
regulators, Bcl-2 and Bax, in uterine tissues during pregnancy. Uterine Baxcc mRNA 
increased in early gestation and declined steadily between days 3 and 19. The bcl-2 
message, however, was undetectable in the uterus during gestation. On day 3, three days 
prior to the initiation of antimesometrial decidual apoptosis, Bax was expressed in pre-
decidual stromal cells. On day 9.5, two days prior to mesometrial decidual apoptosis, Bax 
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was expressed in the mesometrial decidua, but it was undetectable in the antimesometrial 
decidua. The temporal Bax expression m uterine decidual cells suggests a role in decidual 
apoptosis. 
Although the temporal Bax expression and the lack of Bcl-2 expression in the uterus 
suggests that there is a shift toward a cell death program in early gestation, other Bcl-2 
homologues may also be expressed in the pregnant uterus. Examination of uterine tissues 
for the expression of BC1-Xl, an inhibitor of programmed cell death, may help to clarify the 
roles of Bcl-2 family members during pregnancy in the uterus. 
Examining the involvement of GMG cells in decidual apoptosis is an interesting 
possibility. However, this would be technically demanding, because isolating healthy 
GMG cells is particularly difficult, especially in late gestation [5]. However, a histological 
analysis of tissues in late gestation may be informative. According to Delgado et al. [3], 
GMG cells rupture in late gestation spilling their granule contents into the local 
enviromnent. An examination of decidual cell integrity in the surrounding area of GMG 
cell rupture may provide some iudication that GMG cells are involved in decidual cell 
death. However, to test this directly pure populations of GMG ceUs and decidual cells 
would be necessary, and the technologies required to isolate these cells currently remain 
undeveloped. 
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APPENDIX 
EXPRESSION CLONING OF THE MITOGEN REGULATED 
PROTEIN RECEPTOR cDNA 
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Introduction 
Mitogen regulated protein, also known as proliferin (MRP/PLF), is a member of 
the prolactin/growth hormone family of proteins (Linzer and Nathans, 1984; Parfett et al., 
1985; Nilsen-Hamilton er a/., 1987). Other members of this family include growth 
hormone, placental lactogens I and n, prolactin, and proliferin related protein. All 
members are important regulators of fetal development and/or maternal changes during 
pregnancy (Soares et al., 1991; Evain-Brion, 1994; Jackson et al., 1994; Nelson et al., 
1995). In the mouse, growth hormone and prolactin are synthesized in the anterior 
pituitary gland, wliile MRP/PLF, the placental lactogens, and proliferin related protein are 
produced in the trophoblastic giant cells of the placenta ( Linzer and Nathans, 1985; Lee et 
al., 1988; Nilsen-Hamilton ef a/., 1988; 1991 Soares era/., 1991; Kelly a/., 1991). The 
trophoblast cells produce these and several other hormones of essential importance to the 
maintenance of pregnancy and to fetal growth and development (Ramsey, 1982; Soares et 
al., 1991). 
For several of ±e prolactin/growth hormone family members, specific receptors 
have been cloned, signal transduction pathways analyzed, and in vivo functions deduced. 
However, for MRP/PLF the events following receptor binding are largely imknown 
(Nelson et al., 1995). Therefore, in order to gain a better understanding of MRP/PLF's 
function during pregnancy, this research has focused on cloning the MRP/PLF receptor 
cDNA. 
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MRP/PLF and the MRP/PLF receptor 
MRP/PLF was originally described as a 34 kD glycoprotein secreted from mouse 
embryonic Swiss 3T3 cells in response to growth factors (Nilsen-Hamilton et al., 1980). 
In vivo, MRP/PLF is synthesized in the trophoblast cells of the mouse placenta between 
days 9 and 13 of gestation and is secreted temporally into the maternal bloodstream peaking 
on day 11 (Lmzei et al., 1985; Lee era/., 1988; Nilsen-Hamilton era/., 1988, 1991). 
Based on sequence homologies to other members of the prolactin/growth hormone family 
and it's temporal expression in the placenta, MRP/PLF was hypothesized to be a hormone 
(Linzer and Nathans, 1984; Lee et al., 1988; Lee and Nathans, 1988). 
A characteristic of hormones is the presence of receptors on specific tissues other 
than their site of synthesis. Therefore, in recent years investigators have searched for 
specific MRP/PLF membrane receptors on fetal and maternal tissues during pregnancy. 
Lee and Nathans (1988) observed that recombinant MRP/PLF binds to the cation 
independent mannose-6-phosphate receptor (also known as the insulin-like growth factor n 
(IGF-II) receptor) on membranes of the fetal and maternal liver and the placenta. 
Additionally, they showed that non-glycosylated MRP/PLF does not compete for the 
binding sites occupied by glycosylated MRP/PLF. Thus, the carbohydrate groups are 
essential for MRP/PLF binding to the mannose-6-phosphate receptor. 
Recently, Jackson and coworkers (1994) showed that MRP/PLF binds to the cation 
independent mannose-6-phosphate receptor on the labyrinth blood vessels of the placenta at 
mid-gestation and stimulates angiogenesis. Proliferin related protein, in contrast, inhibits 
angiogenesis in these same cells, also through the mannose-6-phosphate receptor (Jackson 
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etal., 1994). 
Recent studies in our laboratory indicate that MRP/PLF binds another receptor in 
addition to the mannose-6-phosphate receptor (Nelson et al., 1995). MRP/PLF binds to 
the mammary gland and uterus in a developmentally regulated profile with peak binding on 
days 10 and 11 respectively. In the uterus, MRP binds a single affinity receptor with a 
dissociation constant of 6 x 10 M (Nelson et al., 1995). In addition, members of the 
prolactin/growth hormone family, including prolactin, growth hormone, and placental 
lactogen I, do not compete for binding to this receptor. Moreover, mannose-6-phosphate 
does not compete with MRP/PLF for binding to the uterine receptor (Nelson et al., 1995). 
Thus, MRP/PLF function(s) in vivo may be mediated by more than one type of receptor; 
the cation independent marmose-6-phosphate receptor and the uterine MRP/PLF receptor. 
This hypothesis is in agreement with several recent findings. According to Jackson and 
coworkers (1994), MRP/PLF binding to the mannose-6-phosphate receptor results in 
placental angiogenesis. Binding to the MRP/PLF receptor on uterine membranes, 
however, results in an increase in cellular proliferation (Nelson et al., 1995). The former 
requires that MRP/PLF contain mannose-6-phosphate while the latter does not. This is 
interesting with regard to MRP/PLF processing in vivo. That is, MRP/PLF in the placenta 
contains mannose-6-phosphate, while MRP/PLF secreted into the maternal bloodstream 
does not and therefore may not be capable of binding the mannose-6-phosphate receptor 
(Nelson and Nilsen-Hamilton, 1991). Perhaps the mannose-6-phosphate moeity allows 
MRP/PLF to function in an paracrine manner in the placenta, and following removal of this 
moiety and secretion into the maternal blood stream, MRP/PLF functions in an endocrine 
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fashion. Indeed, other pregnancy related hormones, such as prolactin, have been shown to 
have altered bioactivity depending on their glycosylation states (Markoff et al., 1988; 
Lewis effl/., 1989). 
Expression cloning of the MKP/PLF receptor from mouse uterus 
To more fully understand MRP/PLF's fimction in vivo, one of my research efforts 
was to clone the mouse uterine MRP/PLF receptor cDNA. The approach utilized was an 
expression cloning technique that has been used successfully in recent years to clone many 
cell surface receptors (Seed and Aruffo, 1987; Gearing et al., 1989; Arai et al., 1990; 
Mathews and Vale, 1991; Lm etal., 1991, 1992; Kluxenefa/., 1992; Chen era/., 1993; 
Sandra et al., 1995). These receptors were cloned based on their ability to bind ligand 
following expression of a cDNA library in mammalian cells. Unfortunately, I was 
unsuccessful in isolating a MRP/PLF receptor cDNA using this technique. This report 
describes the techniques used to clone the MRP/PLF receptor cDNA and a discussion of 
potential limitations of this approach in cloning cell surface receptors. 
Materials and methods 
cDNA library construction 
Total RNA was isolated from day eleven pregnant CF-1 mouse uterine tissue by the 
single step guanidinium thiocyanate method (Chomczynski and Sacchi, 1987). 
Polyadenylated mRNA was purified from day eleven total uterine RNA by affinity 
chromatography on oligo (dT) cellulose (Davis, et al., 1986). cDNA was sjoithesized from 
day eleven uterine poly (A*) mRNA using a Boehringer Mannheim cDNA synthesis kit 
(catalog # 1117831). Blunt ended cDNAs were ligated to nonpalindromic BSTXl adaptors 
(Invitrogen) and then subjected to size selection on a Sepharose 4B spin column 
(Pharmacia). cDNAs larger than 0.5 kb were ligated into the expression vector, pCDM8 
(a gift from Dr. Brian Seed), and electroporated at 2.5 kV, 25 /LIF, and 200 ohms resistance 
into the Escherichia coli strain, MC1061/P3. The transformed bacteria were plated on 
ampicillin (12.5 ptg/ml) and tetracycline (7.5 /ig/ml) selective media. This procedure 
yielded approximately 250,000 primary recombinants with cDNA inserts ranging in size 
from 0.45-6 kb. The bacterial colonies were scraped off the dishes and stored in pools of 
25,000 clones each in 15% glycerol at -70°C. 
Preparation of electrocompetent bacterial cells 
A single MC1061/P3 bacterial colony was inoculated into 50 ml of LB containing 
25 /ig/ml kanamycin. The culture was grown for 12-16 h at 37°C and 180 revolutions per 
minute (rpm). One liter of LB containing 25 uglxol kanamycin was inoculated with the 50 
ml overnight culture in a sterile two liter flask. The cells were grown at 37°C with constant 
agitation (180 rpm) imtil the culture reached an optical density of 0.5-0.6 at 550 
nanometers. The bacterial cells were transferred to sterile centrifuge bottles, placed on ice, 
and stored in the cold room for 30 minutes. The remainder of the cell preparation was 
performed in the cold room, except for the centrifugation steps. The cells were spun at 
3,500 rpm in an GSA rotor for 15 minutes at 0°C. The supernatant was removed, and the 
bottles were placed back on ice. Subsequently, the cells were resuspended in one liter of 
pre-chilled sterile deionized, distilled water (Coming Mega Pure Still). After complete 
resuspension, the cells were spun at 3,500 rpm in an GSA rotor for 15 min at 0°C. The 
supernatant was removed and the bottles were immediately placed on ice. The cells were 
resuspended as before, except with only 500 ml of water, and the centrifugation at 3,500 
rpm was repeated. The cell pellet was resnspended in 40 ml of sterile cold 10% glycerol in 
deionized, distilled water, transferred to a pre-chilled 50 ml centrifuge mbe, and spun at 
5,800 rpm in an SS34 rotor for 15 min at 0°C. The glycerol was quickly decanted and the 
cell pellet resuspended in 1.5 ml of 10% glycerol. Forty microliters of cells were 
aliquoted into sterile 1.5 ml mbes pre-chilled on dry ice and stored at -70°C until needed. 
Plasmid DNA isolation from library pools 
Aliquots of the frozen library pools were grown overnight in 10 ml of superbroth 
containing ampicillin (12.5 ^tg/ml) and tetracycline (7.5 /xg/ml), and plasmid DNA was 
isolated from 5 ml of the culture using a modified alkaline-Iysis/poly ethylene glycol 
precipitation procedure provided by the Iowa State University DNA Sequencing and 
Synthesis Facility. 
COS-1 cell transfection 
On the day prior to transfection, 35,(XX)-50,000 COS-1 cells (a gift of Francis 
Weis) were seeded onto Nunc chamber slides. Transfections were performed using a 
DEAE-Dextran method generously provided by Dr. Rory Fisher as foUows. For each 
chamber slide, 3 jxg of plasmid DNA was added to phosphate buffered saline (PBS) (137 
mM NaCl, 2.7 mM KCl, 4.3 mM Na2HP04, 1.4 mM KH2PO4, 5 mM MgCI^, 0.9 mM 
CaClj, pH 7.3) at 37°C to a final volume of 475 /il and vortexed. Twenty five microliters 
of 10 mg/ml DEAE-Dextran in phosphate saline (PS) (150 mM NaCl, 15 mM sodium 
phosphate, pH 7.3) was added to the DNA/PBS solution and the mixture was vortexed. 
The cells were washed twice with PS (37°0, the transfection mixture from above was 
added, and the cells were placed in an incubator at 37°C with a water saturated atmosphere 
containing 10% CO2 in air for 30 min. Subsequently, 2 ml of growth medium (Dulbecco's 
Modified Eagle's Medium containing 0.45% glucose, 10% calf serum, 10 Units/ml 
penicillin, 10 Units/ml streptomycin) supplemented with 100 ^^M chloroquine was added to 
the cells, and they were placed in the incubator for another two h. The transfection 
mediimi was aspirated, and the cells were treated for 2.5 minutes with 10% dimethyl 
sulfoxide (DMSO) in PBS at 37°C. The DMSO solution was replaced with fresh growth 
mediimi and the cells were assayed for MRP receptor activity 48-60 h later. 
Binding assay on transfected COS-l ceUs and autoradiography 
Transfected COS-1 cells were incubated in serum-firee growth medium for 30-60 
min in an incubator with a water saturated atmosphere containing 10% CO2 in air at 37°C . 
Next, they were washed twice with Tris-buffered saline (TBS) at 4°C and incubated for 90 
min at 4°C in Hanks Balanced Salts, 30 mM HEPES, 1 mM mannose-6-phosphate 
containing 5ng/ml '^I-MRP/PLF (between 2 x 10^-2 x 10® cpm per dish, 1 ml final 
volume). The cells were washed 5 times with TBS (2 ml) at 4°C and then fixed in 0.2% 
glutaraldehyde, 2% formaldehyde in PS, pH 7.4 for 60 min at 4°C. The cells were 
washed twice with TBS at 4°C, twice with deionized water, and the plastic chamber was 
removed from the slide. The slides were dipped in 0.5% gelatin, 0.05% chromium 
potassium sxilfate at 37°C and allowed to dry at 37°C. Subsequently, the slides were 
dipped in a 1:1 mixture of Kodak NTB2 autoradiographic emulsion and 0.2% aerosol-OT 
at 45 °C and allowed to dry flat. The slides were placed in light-proof boxes containing 
silica gel at 4°C for 3-5 days and then developed with Kodak Dektol Developer and Kodak 
Fixer according to the manufacturer. The cells were viewed using darkfield, phase contrast 
and brightfield microscopy on a Zeiss microscope. 
lodination of proteins 
MRP/PLF purified from conditioned mediimi of BALB/c normal liver cells or 
Endothelin-1 (Sigma E7764) was iodinated using Pierce lODO-BEADS lodination Reagent. 
Briefly, 1 mCi of '^I-Na (Amersham) was incubated with one lODO-BEAD and 50 mM 
sodiirai phosphate, pH 7.5 at room temperature for 5 min. 1-3 /xg of protein was added to 
the above mixture, and the incubation was continued for another 10 min. The reaction 
(200 ^1) was diluted to 1 ml with 50 mM sodium phosphate, pH 7.5, and the labeled 
protein was purified on a Biorad 10-DG column pre-equilibrated in 50 mM sodiimi 
phosphate, 1 % bovine serum albumin (BSA), pH 7.5. 1 ml fractions were eluted with 50 
mM sodium phosphate, pH 7.5 into mbes containing 100 /tl of 1 % BSA. Each fraction 
was analyzed by trichloroacetic acid (TCA) precipitation, and fractions containing the 
highest percent TCA precipitable protein were used in experiments. In general, fractions 4 
and 5 contained the majority of labeled protein at 80% or greater TCA precipitable protein. 
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lodinated proteins were also resolved by sodium dodecyl sulfate-polyacrylamide gel (SDS-
PAGE) electrophoresis, Coomassie stained, dried, and subjected to autoradiography to 
confirm that the proteins had been iodinated. 
Sequencing and analysis of cDNA clones 
Positive clones identified in the library screen were partially sequenced by the Iowa 
State University DNA Sequencing and Synthesis Facility and analyzed with GCG software. 
Results and Discussion 
Expression cloning in COS cells 
The most successful method used recently to clone cell surface receptors has been 
expression cloning in COS ceUs (Seed and Aruffo, 1987; Gearing et al., 1989; Arai et al., 
1990; Mathews and Vale, 1991; Lin et al., 1991, 1992; BQuxen et al., 1992; Chen et al., 
1993; Sandra et al., 1995). Briefly, this system involves dividing a cDNA expression 
library into several pools, transfecting the cDNA pools into simian COS cells, and 
screening for the receptor of interest by performing binding assays on the transfected cells 
with labeled ligand. Subsequently, the cells (fixed to microscope slides) are dipped in 
autoradiographic emulsion and developed after a period of exposure. Individual COS cells 
expressing the receptor of interest can be identified using darkfield microscopy by the 
presence of distinct silver grains on the cell surface. Upon isolation of a positive cDNA 
pool, the library is further subpooled and rescreened until a pure clone is identified. 
This technique was chosen to isolate the MRP/PLF receptor cDNA for two reasons. 
First, it does not require any previous knowledge regarding receptor structure which is 
often necessary to purify receptor proteins. Secondly, this technique eliminates signal to 
noise problems common to other techniques by allowing the investigator to microscopically 
observe single cells expressing the receptor of interest (Lin et al., 1992). 
Detection of endothelin receptors with endothelin-1 and autoradiography 
To verify that the binding assay and autoradiography required for the day eleven 
uterine cDNA library screen were working properly, the binding assay was performed with 
a known system, specifically, endothelin-1 binding to the endothelin receptor. The 
endothelin receptor cDNA was cloned using this expression cloning method (Lin et 
a/., 1991). Briefly, COS-1 cells were transfected with the endothelin receptor cDNA ( a 
gift from Dr. Herb Lin), and the cells were assayed for '^I-endothelin-1 binding as 
described in the materials and methods. When viewed under darkfield microscopy, COS-1 
cells transfected with the endothelin-1 receptor cDNA displayed distinct silver grains on the 
cell surface, indicative of '^I-endothelin-1 binding (Figure 1), whereas mock transfected 
COS-1 cells showed little or no silver grains (Figure 2). 
Screening of the day eleven mouse uterine cDNA expression library 
The day eleven uterine cDNA expression library (250,000 clones) was divided into 
pools of 25,000 clones for use in the initial receptor screen. Figure 3, shows a typical 
MRP/PLF preparation used in the binding assay. In the initial screen, one pool (cDNA 
pool 6) displayed two positive cells for MRP/PLF binding (Figure 4). This pool was 
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subdivided into subpools of 4,000 clones each, and then into subpools of 500 clones each 
and then to smaller sized pools and rescreened for MRP/PLF receptor binding (Figure 5). 
We initially observed small increases in the number of positive cells as the pool sizes were 
decreased. Specifically, in the pools of 4,000 clones, we observed one positive cell in 
eight of ten pools. Upon subdividing to 500 clones per cDNA pool, we observed several 
pools with between two and six positive cells. In each case, the cDNA pool chosen for 
further analysis was the one displaying the highest number of positive cells and had the 
highest receptor expression, i.e. '^I-MRP/PLF binding. 
We began to become concerned with the receptor screen when the cDNA pool sizes 
were of 500 clones each. At this point seven of ten pools showed between two and six 
positive cells. One would expect that imless the receptor cDNA was very abimdant in the 
library, that when we subdivided into smaller pools, there would be very few positive pools 
(one or two). Additionally, with only 5(X) cDNAs per pool, one would expect there to be 
more than six positive cells, since upon each subdivision of the cDNA library, the 
MRP/PLF receptor cDNA should have become amplified. Although the results were not 
what we had anticipated, we continued the screen based on the following: 1) Perhaps we 
were observing binding to a truncated MRP/PLF receptor. If this truncated receptor bound 
MRP/PLF with lower affinity, we may have been on the threshold of detectable binding. 
2) There was also the possibility that MRP/PLF binds to a multisubimit receptor. If we 
were detecting binding to a single receptor subunit that has lower affinity for MRP/PLF, 
again we may have been on the threshold of detection. With the above possibilities in 
mind, the receptor screen was continued until a pool of four cDNA clones was obtained, 
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which when expressed m COS-1 cells gave only nine positive cells (Figure 6). The four 
cDNAs (F4, Fll, F16, and M13) were partially sequenced and analyzed with GCG 
software to determine if they had sequence homology to known receptor cDNAs. 
Each of the four cDNAs obtained in the screen was analyzed using the basic local 
alignment search tool (BLAST) and MAP in GCG. BLAST was used to compare the 
cDNAs to the sequence databases at both the nucleic acid and the protein levels. MAP was 
used to determine ail possible open reading frames. Clones F4 and M13 are partial cDNAs 
patented by Dr. Brian Seed. According to the databases, the sequences are derived from an 
unknown organism and have homology to many bacterial cloning vectors. Interestingly, 
Dr. Seed developed receptor cloning in COS cells, and he cloned the same cDNAs using 
this technique. The significance of this finding is currently unknown. Analysis of clone 
F16 sequence revealed a polyadenylation signal and poly-A tail in the five prime region of 
the clone. Thus, it was inserted into the vector in the wrong orientation, and therefore 
would not be expressed properly. Finally, clone Fll has 98-100% identity to a portion of 
rat, mouse, pig, hamster, and human desmin at the protein level. 
Conclusions 
There are several possible explanations why we failed to clone the MRP/PLF 
receptor using expression cloning. This method required that the receptor ligand binding 
and transmembrane domains be expressed on the cell surface of the COS-1 cells in order 
for the ligand to bind and be detected. Most growth factor and hormone receptors are 
inserted into the plasma membrane with their amino termini exposed to the extracellular 
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environment (type I receptors). Therefore, in order to express the fiiU ligand binding 
domain, a coiiq)lete cDNA must be synthesized. If the reverse transcriptase used in oligo-
dT primed cDNA synthesis did not proceed to the five prime ends of the mRNAs, the 
receptor may have been expressed with a truncated ligand binding domain. As suggested 
previously, a truncated receptor may have lower affinity for it's ligand, and therefore 
would be difficult to detect with the ligand bioding assay. Furthermore, the ligand binding 
assay may not have been efficent enough if we were observing binding to a single receptor 
subunit requiring multisubimits for high affinity binding. 
In addition to the possibility of a truncated or multisubunit receptor, MRP/PLF 
itself may have contributed to our difficulties, because it is an extremely sticky protein. 
During the screening process we began to consider that many of the positive cells might 
have been "false positives" or artifacts of the system due to non-specific binding of MRP to 
proteins on the COS-1 cell siuface. However, we rarely observed these "false positives" 
on control slides (mock transfected cells). If MRP/PLF binds non-specifically to some 
types of proteins more than others, it is possible that we were observing non-specific 
MRP/PLF binding to cell surface proteins that were expressed in the COS cells fi-om the 
cDNA library. This would explain why the "false positives" were observed variably in the 
library screen. 
In addition to non-specific MRP/PLF binding to cell surface proteins, MRP/PLF's 
glycosylation state may have affected receptor binding. There is evidence m the literature 
that a protein's glycosylation state can affect its binding affinity to cell surface receptors, 
and ultimately its bioactivity. Specifically, Markoff et al. (1988) and Lewis et al. (1989) 
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showed that glycosylated prolactin is significantly less active in receptor binding assays and 
has less bioactivity than non-glycosylated prolactin. We used 1 mM mannose-6-phosphate 
in our binding assays to prevent binding to the mannose-6-phosphate receptor. However, 
other glycosyl groups may contribute to MRP/PLF's affinity and specificity for the uterine 
MRP/PLF receptor. If the '"I-MRP/PLF protein used in the library screen was partially 
deglycosylated, it's affinity for the MRP/PLF receptor may have been altered, and 
therefore may have prevented us firom detecting high affinity binding. 
Unfortunately, difficulties with this cloning metiiod are not discussed in the 
literature. However, Paul Kelly and coworkers recently cloned a fish prolactin receptor 
using this technique (Sandra et al., 1995). The initial goal of the project was to clone 
several different receptors firom fish and amphibians, but it was only effective with the fish 
prolactin receptor. In the prolactin receptor screen, Kelly observed a large increase in the 
number of positive cells as the cDNA pool size was decreased. Additionally, he observed 
"false positives" in the system which he was unable to explain and attributed failure in 
cloning the other receptors partly to this problem (personal communication). 
I believe that our failure in cloning the MRP/PLF receptor may have been a 
combination of several problems. We may have observed MRP/PLF binding in the first 
screen (Figure 3) and then lost it by choosing "false positives" in later screens. I am 
certain now that we were observing artifacts in some instances, since we did not observe 
large increases in receptor expression as the cDNA pool size decreased. However, I do not 
fully understand how the artifacts were generated. In addition, the original pool we 
described as positive, may have itself been an artifact, and therefore, the screen may not 
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have been at all selective for the MRP/PLF receptor. Our initial studies with endothelin 
showed that we cotild detect receptor expression with this method. Therefore, it remains 
unclear why we were unsuccessful. 
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Figure 1. EndotheIin-1 binding to COS-1 cells expressing the endothelin receptor. Images 
generated with a video camera attached to a Zeiss microscope using NIH-Image software, 
20X magnification. A). Darkfield B). Nomarski Q. Phase Contrast. 
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Figure 2. Endothelin-l binding to mock-transfected COS-1 cells. Images generated with a 
video camera attached to a Zeiss microscope using NIH-Image software, 20X 
magnification. A). Darkfield B). Phase Contrast. 
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Figure 3. Radioiodinated MRP/PLF resolved on a 15% SDS-PAGE gel. 
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Figure 4. '^I-MRP/PLF binding to COS-1 cells transfected with cDNA library pool 6. 
Photographs were taken on a Zeiss microscope, 20X magnification. A). Darkfield B). 
Brightfield. 
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Figure 5. '"I-MRP/PLF binding to COS-1 cells transfected with uterine cDNA library 
subpools. A, B). Representative photographs from a positive subpool containing 4,000 
clones. C, D). Representative photographs from a positive subpool containing 500 clones. 
Photographs were taken on a Zeiss microscope at 20X magnification. A and C, Darkfield. 
B and D, Brightfield. 
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Figure 6. '^I-MRP/PLF binding to COS-1 cells transfected with the final uterine cDNA 
library subpool containing four different cDNAs. Photographs were taken on a Zeiss 
microscope at 20X magnification. A). Darkfield B). Brightfield. 
